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Peptides play key roles in many biological processes. For example, the antigenic 
peptides are presented on the surface of the cell by the major histocompatibility complex 
(MHC) molecule and induce the immunological response. Peptides also work as 
hormones and transport many kinds of signals to target cells. Moreover, peptides cause a 
kind of disease known as amyloidosis, where peptides become insoluble and are 
deposited in organs. All physiological phenomena mentioned above are involved in 
peptide-protein (or peptide-peptide) interactions. It means that regulating specific 
peptide-protein interactions using an artificial high-affinity peptide would result in the 
control of the specific biological process. Angiotensin II receptor blocker (ARB) is one 
of examples based on this idea. ARB prevents the binding of angiotensin II to its receptor 
proteins, resulting in the reduction of the blood pressure. Peptide itself is also a potent 
inhibitor of peptide-protein (or protein-protein) interactions. Phan et al. succeeded to 
design 12-mer peptides binding to MDM2 and MDMX with high affinities [1]. Peptide 
inhibitors against various Src Homology 2 (SH2) domains were also identified [2-4]. 
Recently, therapeutics targeting protein-protein interactions are expected to fulfill unmet 
medical needs. There are increasing interests in rational design techniques of high affinity 
peptides. 
Bioinformatic approaches have been widely used for the prediction of the amino-acid 
sequence of the binding peptide especially for the MHC class I and II molecules [5-7]. In 
these approaches, some scoring functions (such as a score matrix) were constructed based 
on known amino-acid sequences of binding peptides. These sequence-based approaches 
are useful in reducing candidate sequences in a short time, but the reliability highly 
depends on the quality and the quantity of the available experimental data. Thus, these 
applications are limited to well-known protein targets. 
A structure-based approach is also a rational technique to design binding molecules.  
This approach has received strong attentions as increasing the number of information 
concerning three-dimensional (3D) structures of biomolecules. Today, numerous 
- 9 - 
 
techniques, including molecular simulations, are available for utilizing the 3D structures 
of biomolecules. Structure-based molecular design techniques use the 3D structures of 
the complex of receptor proteins and the ligand molecule to predict binding affinities. 
Because structure-based approaches do not require experimental data concerning known 
binding molecules, they are expected to be applicable to a wide variety of therapeutic 
targets. 
In this study, we discuss the structure-based design of peptides based on molecular 
docking. Structure-based molecular design consists of several stages according to their 
computational costs. Molecular docking is used in the early stage of the molecular design 
because of its computational efficiency. Therefore, molecular docking is used with 
thousands of compounds in order to discriminate binders from non-binders. Detailed 
binding affinities will be further investigated in the next stages.  
Molecular docking has two main purposes: predictions of the binding conformations 
and of the binding affinities. The important purpose of molecular docking is to predict 
binding conformations of the ligand molecule to its receptor proteins. Programs for 
molecular docking generate numerous conformations of the ligand molecule and judge 
them using a scoring function, called docking score. Docking scores are also used as the 
binding affinities in order to rank ligand molecules. Sometimes, other scoring functions 
are used for re-evaluating the binding affinities using binding conformations predicted by 
molecular docking (known as rescoring). 
Molecular dockings have been widely used in traditional drug discoveries. They have 
been supposed to be used with drug-like small molecules. Because peptides have different 
characteristics from drug-like small molecules, conventional molecular docking cannot 
be applied to the peptide design. In chapter 1 of this study, we demonstrate the inability 
of conventional programs to predict correct binding conformations of peptides. To solve 
this problem, we developed a program for molecular docking of peptide. We incorporated 
the potential energy function of molecular mechanics and an implicit solvent model to 
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our scoring function. We used a GPGPU technology [8] to accelerate computations of our 
molecular docking program. We show performances of our program on predictions of 
binding conformations of peptides using various peptide-protein complexes. 
Conventional programs for molecular docking have inabilities to predict not only the 
binding conformations but also the binding affinities of peptides. We demonstrate those 
in chapter 3. We tried to solve this problem by applying Molecular Mechanics and Poisson 
Boltzmann Surface Area (MM-PBSA) method as rescoring of the binding affinities [9-
11]. However, Poisson Boltzmann (PB) implicit solvent, which is used in MM-PBSA, has 
low estimation accuracy of the polar contribution of the solvation free energy. In chapter 
2, we improve the accuracy of PB by modifying PB radii, which are important parameters 
for PB calculations. Our PB radii gave high performances on estimations of both the 
solvation free energies of single molecules and the binding affinities of peptide-ligands 
predicted by MM-PBSA. 
In chapter 1 and 2, we improved the estimation accuracies of the binding 
conformations and the binding affinities of peptides to their receptor proteins. In chapter 
3, we combined and applied our improved methods to in silico screening of peptides. We 
measured the performances of our method on discriminating the binding peptides of 
several SH2 domains from a small set of peptides. In this chapter, we also examined the 
effect of the reorganization of ligand molecules on the performances of molecular-
docking based approaches. Our results provide useful information for more large-scale 
screening of peptides. 
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1.1. Introduction 
As increasing the number of three-dimensional (3D) structures of biomolecules, 
many computational techniques have been developed to utilize these 3D structural data. 
Structure-based drug design (SBDD) is one of these techniques to design binding 
molecules using the 3D structures of the target proteins. 
The ligand-based drug design (LBDD) techniques, such as a structure-activity 
relationship (SAR), highly depends on the quality and the quantity of the available 
experimental data. Thus, their applications were limited to the known therapeutic targets. 
Moreover, LBDD is not suited to find molecules having different scaffolds from known 
binding molecules. 
SBDD predicts the binding affinities using the complex structures of the ligand 
molecules and the receptor proteins. The complex structures are usually predicted by 
molecular simulations, called molecular docking. Molecular docking predicts the binding 
conformations of ligand molecules to their target protein according to the score function, 
called docking score. Docking scores are also used as the binding affinities to rank ligand 
molecules. Because the computational time of molecular docking is very short, molecular 
docking-based approaches are used with thousands of compounds in chemical databases. 
Conventional docking programs have been supposed to be used with drug-like 
small molecules. It is reasonable because many studies of the traditional drug discovery 
have devoted to find the small molecules binding to their target proteins. Recently, 
biomolecular drugs, such as vaccines, hormones, and antibodies, are also known to be 
effective in many types of diseases. Some of these diseases are involved in protein-protein 
interactions. Due to the large contact interface of protein-protein interactions, small 
molecules, whose typical molecular weight is smaller than 500 Da, is not suitable for 
inhibition of the binding between proteins. Instead of small molecules, larger amino-acid 
based molecules, peptides or small proteins, have received considerable attentions in 
recent years. 
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We can classify these amino-acid based molecules into two types: molecules having 
stable secondary structures of proteins and those having no stable secondary structures of 
proteins. The former molecules maintain their secondary structures through their bindings 
to receptor proteins. The same behaviors are expected in molecular docking: most part of 
the conformations of peptides will be kept during the simulation. To apply molecular 
docking to these peptides, an alternative docking algorithm has been developed and 
known as protein docking [12-14]. On the other hand, the other type of molecules has no 
stable secondary structures of proteins. They are expected to change their conformations 
through binding to their target proteins as small molecules do. Therefore, similar 
algorithms to conventional molecular docking can be applied to these peptides. However, 
peptides have different characteristics from small molecules. It is necessary to take into 
account the characteristics of peptides to molecular docking. 
Peptides have many rotatable bonds and many polar functional groups. Many 
rotatable bonds enlarge the conformational search space in molecular docking. It results 
in the increase of the number of the evaluations of binding conformations until getting 
optimal binding conformations, as compared with drug-like small molecules. 
For practical use, it may be necessary to reduce the conformational search space 
artificially by adding some positional restraints on several atoms of the ligand molecule. 
For example, positional restraints based on backbone atoms are efficient if the reference 
structure of the protein-peptide complex is available. Thus, it is preferred to be able to set 
up flexible positional restraints easily into simulations. 
The second characteristic of peptides is many polar functional groups that affect the 
scoring function of molecular docking. As described in the proposal by Lipinski [15], 
drug-like small molecules are lipophilic and contain a few polar functional groups. For 
the drug-like small molecules, a few polar interactions, such as hydrogen bonds, between 
the ligand- and the receptor atoms are dominant in the formation of the ligand-receptor 
complex. On the other hand, peptides have many polar functional groups. Peptides can 
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form many polar interactions with not only receptor atoms but also solvent atoms. It is 
crucial to take into account the solvation effect in the scoring function for peptide docking. 
Implicit solvents can estimate the solvation free energy of the solute without explicit 
conformational sampling of water molecules. However, the computational cost of implicit 
solvents is still high for molecular docking. 
In this study, we developed our program for molecular docking. We incorporated 
the implicit solvent into the scoring function. We attempted to solve the problem of the 
high computational cost of the implicit solvent by accelerating the computations using 
general-purpose computing on graphics processing units (GPGPU) technology. GPGPU 
utilizes an extreme computational power of GPU for general-purpose computations, not 
only for image processing. GPU consists of many computing units, and we can consider 
it as a parallel machine for single instruction, multiple data (SIMD) operations. To bring 
out the full performance of GPU, computational algorithms must be highly optimized for 
SIMD parallel processing. 
Molecular docking is highly suited to SIMD computing. Procedures of molecular 
docking consist of two parts: the generation and the evaluation of the binding 
conformations. In the generation of binding conformations, the program enumerates 
candidate-conformations of the ligand molecule in a binding site of the receptor protein. 
In the evaluation of binding conformations, docking scores of each conformation are 
calculated from the scoring function. These two procedures are iterated until docking 
scores are well converged. In the two parts, the procedure for the evaluation of the binding 
conformations constitutes a large portion of the total computational cost. Therefore, it is 
reasonable to accelerate this part of calculations. This procedure can be easily 
parallelizable because the evaluation of each conformation is data-independent on each 
other. It enables to process each evaluation in parallel. Furthermore, computations of the 
scoring function are also easily parallelizable. A large part of the computational cost in 
the scoring function is attributed to the calculation of pairwise interactions between atoms 
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in the ligand-receptor complex molecules. Each pairwise interaction is also data-
independent on each other and can be calculated in parallel. 
For these reasons, molecular docking is highly suited to parallel computations using 
GPU. It is expected to reduce the computational time significantly and to enable us to 
apply molecular docking to peptides in a practical time scale. 
In this chapter, we first describe the specification of our program and how we 
accelerate the computations of molecular docking using GPU. In following sections, we 
measured the performance of our program in the respect of the computational time and 
the estimation-accuracy of binding conformations using several proteins. 
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1.2. Theory and Specification 
We developed our program for molecular docking using the GPU acceleration. The 
performance of molecular docking is highly dependent on the scoring function and the 
algorithm for the generation of binding conformations. First, we describe these two 
features implemented in our program. Next, we give the brief explanation of each 
procedure of our program. 
 
1.2.1. Scoring Functions 
We described that it is important to take into account the solvation effect of the solute 
in molecular docking of peptides. We incorporated the generalized born implicit solvent 
(GB) into our scoring function [16, 17], which is commonly used in molecular simulations. 
GB estimates the polar contribution of the solvation free energy (GGB), and it is familiar 
with the potential energy function (Force Field) of Molecular Mechanics (MM). Our 
scoring function DS is represented as follows: 
𝐷𝑆 =  𝑉𝑀𝑀 + 𝐺𝐺𝐵 + 𝑉𝑟𝑒𝑠𝑡𝑟𝑎𝑖𝑛𝑡 
where VMM is the potential energy function of AMBER force field (ff99SB) [18], and 
Vrestraint is a user-defined harmonic penalty described below. The standard form of the VMM 
is represented as follows: 
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𝑉𝑀𝑀 = ∑ 𝑘𝑅(𝑅 − 𝑅𝑒𝑞)
2
𝑏𝑜𝑛𝑑𝑠
+ ∑ 𝑘𝜃(𝜃 − 𝜃𝑒𝑞)
2
𝑎𝑛𝑔𝑙𝑒𝑠
+ ∑
𝑘𝜙
2
{1 + cos(𝑛𝜙 − 𝛾)}
𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
+ ∑ 𝜖𝑖𝑗 [(
𝑟𝑒𝑞
𝑟𝑖𝑗
)
12
− 2 (
𝑟𝑒𝑞
𝑟𝑖𝑗
)
6
]
𝑎𝑙𝑙 𝑎𝑡𝑜𝑚
𝑝𝑎𝑖𝑟𝑠(𝑖,𝑗)
+ ∑
𝑞𝑖𝑞𝑗
𝜖𝑟𝑖𝑗𝑎𝑙𝑙 𝑎𝑡𝑜𝑚
𝑝𝑎𝑖𝑟𝑠(𝑖,𝑗)
 
where kR is a bond force constant; R, a bond-distance; Req, an equilibrated bond-distance, 
kθ, an angle force constant; θ, the angle; θeq, an equilibrated angle; kϕ, a dihedral force 
constant; n, a multiplicity of the dihedral function; ϕ, a dihedral angle; γ, a phase shift; ϵij, 
a force constant for the Lennard-Jones (LJ) potential; req, an equilibrated LJ distance; r, a 
distance between atom i and j; q, a partial charge; ϵ, a relative dielectric coefficient. MM 
potential energy function includes bond, angle, dihedral, van-der Waals (Lennard-Jones 
potential), and electrostatic (coulomb potential) terms. In our docking program, the 
effects from bond-stretching and angle-bending are neglected (fixed during the 
simulation) in order to simplify the problem. 
In the Lennard-Jones potential function, the 12th order of the repulsive term is 
ordinary used due to a good approximation for the Pauli repulsion and a computational 
efficiency. In the docking simulation, it is better to use more soft repulsion term because 
it is difficult to generate conformations of the ligand molecule without any steric crashes. 
We used 8th order instead of 12th one. Fourth term of the equation above is replaced by 
VLJ8-6: 
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𝑉𝐿𝐽8−6 = ∑ 𝜖𝑖𝑗 [3 (
𝑟𝑒𝑞
𝑟𝑖𝑗
)
8
− 4 (
𝑟𝑒𝑞
𝑟𝑖𝑗
)
6
]
𝑎𝑙𝑙 𝑎𝑡𝑜𝑚
𝑝𝑎𝑖𝑟𝑠(𝑖,𝑗)
 
where the coefficients were determined to have the same depth of the potential well at the 
same distance as those of 12th order (Figure 1.1). 
Additionally, we used scaled distance for non-bonded interactions to ease serious 
steric crashes. Scaled distance 𝑟𝑖𝑗
′  was determined based on the equilibrated distance req 
of Lennard-Jones potential of each atom pair. 𝑟𝑖𝑗
′  was represented as follows: 
𝑟𝑖𝑗
′ = {
𝛽 − 𝛼
𝛽2𝑟𝑒𝑞
𝑟𝑖𝑗
2 + 𝛼𝑟𝑒𝑞
𝑟𝑖𝑗
          
(𝑟𝑖𝑗 < 𝛽𝑟𝑒𝑞)
(𝑟𝑖𝑗 ≥ 𝛽𝑟𝑒𝑞)
 
where α and β are scaled factors. We used 0.45 and 0.55 for α and β, respectively.  
 
Positional Restraints 
   Positional restraint is a reasonable solution to reduce the conformational search space 
in the molecular docking of peptides. In our program, two types of positional restraints 
are available and easy-to-use. One option is to fix a fragment of the ligand molecule at 
their input positions. It is effective if a portion of the ligand molecule works like an anchor. 
Another option adds the harmonic penalty (Vrestraint) according to the position of the 
specified atoms of the ligand molecule. The harmonic penalty Vrestraint is represented as 
follows: 
𝑉𝑟𝑒𝑠𝑡𝑟𝑎𝑖𝑛𝑡 = {
0
  𝑘(𝑟 − 𝑟𝑐𝑢𝑡𝑜𝑓𝑓)
2            
(𝑟 ≤ 𝑟𝑐𝑢𝑡𝑜𝑓𝑓)
(𝑟 > 𝑟𝑐𝑢𝑡𝑜𝑓𝑓)
 
where k is the force constant, and r is the distance from the reference position. The 
harmonic penalty is added only if r is longer than rcutoff. User can set all of parameters for 
the positional restraint arbitrary. 
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1.2.2. Genetic Algorithm 
We used the genetic algorithm (GA) to optimize binding conformations of the ligand 
molecule in the binding site of the receptor protein.  
In our program, the conformation of the ligand molecule is represented in the two 
manners: the Z-matrix and the Cartesian coordinate. The Z-matrix represents the position 
of the atom as a relative position to other atoms. The position of the atom is determined 
by the list of the bond-length, the bond-angle, and the dihedral angles. Furthermore, 
additional six parameters are used to determine the relative orientations between 
molecules. In our program, binding conformations are represented in the form of the Z-
matrix because it can handle the conformational change of the molecule easier than the 
Cartesian coordinate. On the other hand, the Cartesian coordinate is the appropriate 
description for handling the non-bonded interactions between separated atoms. Therefore, 
it is used in the evaluation of the binding conformations: the scoring function are 
calculated using the Cartesian coordinate which are converted from Z-matrix. 
In our GA, new conformations are constructed by applying genetic operators to 
existing conformations: the single-point crossover and the single-point mutation. The 
default ratio for the crossover and mutation operator is 0.7 and 0.3, respectively. Partners 
of the crossover operator are limited to similar conformations of each conformation, 
which are determined by a pairwise Root Mean Square Deviation (RMSD) matrix 
between every conformation. It results in the reduction of the probability of trapping in a 
local minima in the conformational search space. In default, genetic operators generate 
five new conformations (called child-conformations) from each conformation (called 
parent-conformation). The Best conformations in each parent and its child-conformations 
become new parent-conformation in the next iteration (the survival stage of GA). 
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1.2.3. Procedures of Our Docking Program 
Figure 1.2 is a flowchart of the docking procedures implemented in our program. In 
this subsection, we will give brief explanations of each procedure. 
 
 Preparation 
First, input structures of the ligand and the receptor molecules are read in the PDB 
format [19]. Because the conformation of the molecules are represented by the Cartesian 
coordinate in the PDB format, the Z-matrix of the ligand molecule are built from the 
Cartesian coordinate. The parameters for the scoring function (the force field and 
positional restraints) are set in this procedure. 
 
 Initial Pose Generation 
    All conformations in the first iteration are generated by random numbers. The default 
population is 3,000. 
 
 Conversion of 3D Coordinate Systems 
The representation of the 3D coordinate system of each conformation are translated 
to the Cartesian coordinate from the Z-matrix. We used self-normalizing natural extension 
reference frame method for this conversion[20]. 
 
 Pose Evaluation 
Figure 1.3 illustrates detailed procedures for the evaluation of the binding 
conformation. Before the calculation of the scoring function, we prepared a distance 
matrix between all pairs of atoms. This helps to reduce the computational cost because 
most of calculations of distances are duplicated, however the GPU code skips this 
procedure. 
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The conformation of the receptor molecules is fixed during the simulation of 
molecular docking. This approximation enables to reduce a large portion of the 
computation of docking score. Our code calculates the intramolecular- and the 
intermolecular contributions of non-bonded interactions separately. This treatment made 
our codes simple and easy-to-read. 
 
 Selection for Survival 
For the first iteration, conformations having top docking scores in all conformations 
are selected as parent-conformations of the next iteration. For the second or later iteration, 
the best conformations in each family, which is formed from each parent- and its child-
conformations, are selected as new parent-conformations of the next iteration. 
 
 Convergence Test 
    This procedure measures the replacement rate of the parent-conformations by new 
ones in next iteration. If the rate is under than the criterion, the optimization are 
considered to be well converged. 
 
 Next Pose Generation 
If the optimization is not converged, GA generates new conformations using genetic 
operators. First, the distance matrix between all pairs of conformations are calculated to 
determine the partners of the crossover operation in GA. Each parent-conformation 
produces several (five in default) new child-conformations using genetic operators. 
 
 Clustering and Output 
If the optimization is well converged, clustering analysis is performed using all 
parent-conformations of the final iteration. Representative conformations of each cluster 
are written in the PDB format. 
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1.2.4. GPU Acceleration 
We developed our program using CUDA programming environment [8]. In this 
subsection, we describe our GPU computing that accelerates many calculation parts of 
the molecular docking. At first, we summarize CUDA programming model. Next, we 
describe our GPU computing. 
 
 CUDA Programming Model 
Thread Hierarchy 
A thread is a basic execution unit in the CUDA programing model. Threads are 
grouped into thread-blocks, and thread-blocks are grouped into a grid. A function 
executed on GPU is called a kernel function. A kernel function is executed on all threads 
in parallel. Only threads in the same thread-block can synchronize. All thread-blocks are 
distributed to multiprocessors of GPU. Multiprocessors can execute the kernel function 
on several thread-blocks concurrently, but there are severe memory restrictions to 
increase the number of concurrently running threads. Because the resource per one 
multiprocessor is limited, we have to reduce the usage of the resource per thread or per 
thread-block for the rapid computing. The maximum number of the concurrently running 
threads is 1536 and 2048 for Fermi and Kepler architecture, respectively. 
 
Memory Hierarchy 
CUDA provides several types of the memory and they have different properties to 
use efficiently. We will summarize those as follows: 
 
Register is the fastest on-chip memory. All variables declared in the kernel function 
generally resides in the registers. Only threads can read or write registers. The number of 
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registers per multiprocessor is 32K and 64K for Fermi and Kepler architecture, 
respectively. Therefore, to maximize the number of the concurrently running threads, the 
number of registers per thread must be under 20 and 31 for Fermi and Kepler, respectively. 
As increasing the number of required resisters per thread, the number of the concurrently 
running threads per multiprocessor decreased. 
 
Shared memory is as fast as the register if an optimal memory access is achieved. 
Shared memory is divided into 32 banks (each bank is 32-bit word). If all threads access 
different banks concurrently, threads can read or write the memory as fast as the resisters. 
By contrast, if several threads access the same bank, these accesses are serialized (the one 
exception is that the access to the same address can be broadcasted to threads 
simultaneously). User can determine the amount of the shared memory per multiprocessor 
from 16 to 48 KB. This is shared by thread-blocks executed on the same multiprocessor 
concurrently. Therefore, the amount of the shared memory per thread-block determines 
the number of thread-blocks executed on single multiprocessor concurrently. Only 
threads can read or write shared memory. 
 
Global memory is only memory which both CPU and GPU can read and write. 
Access to the global memory is slower several hundred times than that of registers even 
if the optimal memory accesses are achieved. Optimal accesses, known as the coalesced 
access, are required for practical use: the k-th thread accesses the k-th word of the array 
in the global memory. Some of the memory latencies can be hidden by any arithmetic 
operation on different threads. Cache for read from the global memory is available. 
 
    Constant memory is the read-only cache and suitable for broadcasting. The 
constant memory is as fast as the register if all threads read the same address. The size of 
the constant memory is limited to 64 KB. 
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Our GPU programming 
 Preparation for Docking Simulation 
Before the beginning of the optimization process of GA, some preparations for GPU 
computing are required: memory spaces are allocated on the global memory, and some 
parameters are transferred to the global memory and the constant memory in advance. 
This process requires an extra computational time, but it is a little. 
 
 Conversion of 3D-Coordinate System 
We tried to accelerate the function for the conversion of the 3D-coordinate system. 
Due to the data-independence of the conversions of each conformation, we can execute 
these calculations in parallel. However, in the Z-matrix representation, the positions of 
atoms are described as the relative positions to other atoms. Therefore, it is required to 
determine the Cartesian coordinates of atoms sequentially in the order listed in Z-matrix. 
For these reasons, one thread calculates the Cartesian coordinates of all atoms in the one 
conformation sequentially. The threads in the same thread-block calculates the Cartesian 
coordinate of the same atom in the different conformation at the same time. The number 
of threads is the same as that of conformations. 
Before a kernel call, the list of parameters regarding dihedral angles and the relative 
orientation to the receptor molecules are transferred to the global memory. They are read 
by each thread in the coalesced manner. The parameters for Z-matrix (1st, 2nd, and 3rd 
indexes of the reference atoms, the bond-length, and the bond-angles) are loaded from 
the constant memory. The Cartesian coordinates of each conformations are saved to the 
global memory and they are used in following functions. 
 
 Calculation of dihedral potential energy 
In this kernel function, one thread calculates all dihedral-angle potential energies of 
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one conformation. The threads in the same thread-block calculates the potential energy 
of the same dihedral angles in different conformations at the same time. All parameters 
for dihedral-angle terms (four atom indexes, a force constant, etc.) are read from the 
constant memory. Results are saved to the global memory and transferred to CPU 
immediately. 
 
 Realignment of Memory containing Cartesian Coordinates 
At this point, the alignment of the Cartesian coordinates is suited for the case that 
each thread reads the coordinate of the same atom but in different conformations at the 
same time. In the following functions, one thread-block handles one conformation i.e. 
each thread in the same thread-block reads the coordinate of different atoms in the same 
conformation at the same time. To achieve the optimal memory access from the global 
memory in the following function, the memory-realignment are needed for the array 
containing the Cartesian coordinates. This realignment corresponds the transposition of 
the matrix, and the optimal implementation on GPU is well known (included in the sample 
code of a CUDA toolkit). 
After this realignment, the Cartesian coordinates of all conformations are transferred 
to CPU. Computational cost of this function is not discussed because it is too low. 
 
 Calculation of non-bonded interactions 
Calculations of the non-bonded term of MM on GPU are also divided into several 
functions in the similar manner to CPU codes. At first, the effective born radii of 
molecules are calculated, and next the potential energy of MM and GB are calculated. 
Both calculations can be represented as the sum of each pairwise contribution of all pairs 
of atoms. Because these pairwise interactions are data-independent on each other, they 
are easily parallelizable on GPU. Here, each thread in the thread-block associates with 
one particular atom in one particular conformation, and calculates non-bonded 
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interactions with other atoms in the conformation. All threads in the same thread-block 
calculates the interactions with the same atom at the same time. This permits to access to 
the same addresses in the shared memory and the constant memory from all threads. 
There is a slight difference between the CPU and the GPU code. In the CPU code, 
the distances between all atom pairs are calculated in advance, and used these values 
several times. On the other hand, GPU cannot retain such a large amount of data and 
requires to calculate the distances each every time. It results in additional computational 
cost for GPU, but the high computational power of GPU overcomes such a weak point. 
 
 Make Neighbor List 
In this function, each thread in the thread-block associates with one particular atom 
in the one particular conformation. Each thread reads the coordinate of the associated 
atom in different conformations, and calculates the distance between two atoms. Results 
of each thread are summarized on the thread-block as the RMSD value between two 
conformations. 
 
1.2.5. Conformational Search of Single Molecule 
This program can be used for the conformational search of single molecule. Actually, 
our program was used to predict stable conformations of peptides in the unbound state in 
chapter 3. 
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1.3. Methods 
1.3.1. Comparison of Computational Time 
We compared the computational time of our program executed on GPU with those 
on CPU-only. We measured the computational time of each calculation part separately. 
We used the computational time for the first iteration of GA optimization. The number of 
parent-conformations was 3,000 and the number of child-conformations per parent 
conformations was 10, i.e., the computational time for the calculations of the docking 
score of 30,000 conformations and the calculation of RMSDs for 4,498,500 pairs of 
conformations were measured. All computational times were measured 10 times and 
averaged. 
Benchmark tests were employed on a PC with Intel® Core™ i7 4770K (3.4GHz, 
Haswell architecture) and two GPUs with different architectures: nVidia GeForce® GTX 
580 (Fermi) and GTX 780 (Kepler). The CPU-only code was executed using single core 
of CPU. Considering the situation where the molecular docking is carried out, it is more 
efficient to execute multiple programs with different ligand molecules on different CPU 
cores than to accelerate one program by several cores of CPUs. Namely, we can consider 
that the parallelization efficiency of the program for the molecular docking is 100 %. The 
CPU codes were compiled using Intel® C++ Compiler version 13.1.1 with the 
optimization option (-O3 –xHOST –no-prec-div). The GPU codes were compiled by nvcc 
installed in CUDA 5.5 with the optimization option (-O3 –use_fast_math). The 
gettimeday() function in C language was used to measure elapsed times on CPU codes. 
The functions managing the CUDA event were used for GPU codes.  
We used two peptide-protein complexes to compare the computational times: a 
complex of Grb2 SH2 domain with its 8-mer binding peptide (PDB: 1TZE) [21] and GIP 
PDZ domain with its 8-mer binding peptide [22]. The number of the receptor atoms of 
GIP PDZ domain is 1.2 times larger than those of Grb2 SH2 domain, while the number 
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of atoms of ligand molecules are almost same. Structural preparation were carried out as 
follows: three-dimensional structures were downloaded from the Protein Data Bank [19]. 
All protonation states of the solutes were determined by the Protonate3D module of MOE 
[23]. Energy minimizations were carried out in the box of TIP3P waters using the sander 
module of AMBER11 [24]. Then, all waters and ions were removed. 
 
1.3.2. Comparison of Prediction Accuracy of Binding Conformations 
    We compared the prediction accuracies of the binding conformations of the ligand 
molecules to their receptor proteins between our program and a widely-used program, 
GOLD [25]. Here, self-docking was performed using four protein-ligand complexes: Crk 
SH2 domain (PDB: 1JU5) [26], Grb2 SH2 domain [27], Src SH2 domain [28], and GIP 
PDZ domain (same as above). All lengths of the binding peptides of SH2 domains were 
adjusted to 8-mer (XXpYXXXXX: where pY denotes the phosphorylated-tyrosine and X 
denotes any amino acids) in order to maintain consistency with the next chapter. The 3D-
structures of each protein were downloaded from the PDB web site. All protonation states 
of solutes were determined by the Protonate3D module of MOE. The solutes were soaked 
in the box of TIP3P waters and energy-minimizations were employed using the sander 
module of AMBER11. Then, energy-minimized structures were used for self-docking 
(named “min”). In addition, we prepared another structure of each complex structure 
using molecular dynamics (MD) simulations. We performed 2 ns MD simulations at 310K 
for the equilibration. The equilibrated structures were also used for self-docking (named 
“MD”). 
The condition for our molecular docking follows: the number of parent-
conformations was 3,000 and the number of the child-conformations per parent-
conformation was 10. Optimizations by GA were iterated until the replacement rate of the 
conformations was under 15 %. No cut-off schemes was employed for the non-bonded 
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interactions. 
For GOLD, the search efficiency was set to 200%. The option for the early 
termination was off, and the search radius was 20 Å. ChemPLP [29] was used as the 
scoring function. Other parameters were set as default. 
We also examined the efficacy of the positional restraint on molecular docking of 
peptides. In our program, positional restraints were added on every Cα atom of all 
residues of each ligand molecule. Moreover, we added positional restraints on the 
phosphorus atom of the phosphorylated tyrosine of SH2-binding peptides and the 
nitrogen atom of the side chain of the lysine for GIP-binding peptide, because these atoms 
form the strong ionic interactions with the receptor atoms. The phosphorus atom in SH2-
peptide was fixed, while the nitrogen atom was harmonically restrained at the reference 
position. Positional restraints were added if the distance from the reference position was 
longer than 2.0 Å. The force constant was 10.0 kcal/mol/Å2. In GOLD, similar restraints 
were archived by Region Constraints. In this algorithm, extra user-defined score (named 
weight) was added to the docking score if the specified atom located within the specified 
distance (named radius) from the reference position. In this study, we examined several 
weights of 10, 20, and 30, and set the radius of 2.0 Å. The molecular dockings with no 
positional restraints were also performed by both programs.  
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1.4. Results 
1.4.1. Comparison of Computational Time 
Computational times of each calculation part are listed in Table 1-1 and Table 1-2 
for Grb2 and GIP, respectively. Our GPU codes could calculate more than 100 times faster 
than CPU code. Moreover, GTX780 was about 1.7 times faster than GTX580 as the 
overall performance. In every calculation part, GTX780 was the fastest and single core 
of CPU consumed the longest computational times. The total computational time 
executed on GPU for Grb2 was about 2,920 ms and 1,484 ms for GTX580 and GTX780, 
respectively. Computational time executed on CPU in the GPU code was similar between 
GTX580 and GTX780, and it was about 550 ms. The computational time for the memory 
allocations and transfers was under 20 ms per one iteration of GA. 
The computational times of each calculation part increased in almost direct 
proportion to the number of interactions in the peptide-protein complex. Because the 
number of atoms of the ligand molecules in two complexes was almost the same, 
computational times involved with only ligand molecule were similar in the two 
simulations. By contrast, the number of atoms of the receptor molecule in GIP was 1.2 
times as many as those of Grb2. This influence was shown in the computational times 
involved with receptor atoms. The functions handling the intermolecular interactions of 
GIP consumed 1.2 times longer than those for Grb2. The function handling the 
intramolecular non-bonded energy within the receptor atoms consumed about 1.4 (1.2 * 
1.2) times longer computational time for GIP than those of Grb2. 
 
1.4.2. Comparison of Prediction Accuracy of Binding Conformations 
Table 1-3 lists ligand RMSDs of the best solutions from each molecular docking 
using two programs. In every case, both programs could not predict the correct binding 
conformations without any positional restraints. On the other hand, both programs could 
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achieve lower RMSD values by applying positional restraints. In GOLD, the constraint 
weight of 30 was required to accomplish the good predictions in all protein-peptide 
complexes. In this case, the contribution from the constraint term in the total docking 
score raised to three times larger than the native docking score in average. 
In three of four cases, the uses of equilibrated structures from MD simulations 
improved the prediction accuracies of the binding conformations. Although RMSD 
values for Grb2 became worse by using the equilibrated structures, the conformations of 
the central four residues of the binding peptide, which are known as the core binding 
motif of SH2-binding peptides (pYxNx), were predicted correctly. Both the N- and C-
terminal portions of the binding peptide were exposed to the solvents, and their 
conformations were highly fluctuated in the MD simulation. 
 
1.4.3. Total Computational Time 
Total computational times of each program with each protein were measured. The 
averaged total computational times of our program for Crk, Grb2, Src, and GIP were 
3m15s, 3m56s, 3m55s, and 6m50s, respectively. Those of GOLD were 1m55s, 1m58s, 
2m7s, and 2m9s, respectively. Our averaged computational times were varied depending 
on proteins, however GOLD were similar to each other. Our computational times were 
about 1.5 - 3.5 times longer than those of GOLD.  
The computational times of our program were fluctuated in several runs. It was 
caused by the varied number of the iterations of GA optimizations in each run. Because 
our program generates initial conformations using random numbers, the degree of the 
convergence of the docking scores are varied in each run. By contrast, GOLD fixed the 
number of the iterations for optimizations. This resulted in similar computational times 
in every run. 
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1.4.4. Single Precision of Floating Points 
    GPU can process the operations using single precision floating points several times 
faster than those using double precision floating points. We investigated the influence 
from single precision floating points on the docking score by comparing calculated values 
by GPU (single precision) and by CPU (double precision). As a result, there were only 
slight differences on total docking score. The error was under 0.001 kcal/mol in most 
cases. In the molecular docking, docking scores were used only to compare with those of 
other conformations, and these small errors do not influence the comparisons of docking 
scores. For this reason, we concluded that operations using single precision floating points 
are not problematic in the molecular docking. 
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1.5. Discussions 
1.5.1. GPU Architectures 
Although the ratio of theoretical arithmetic capacity of GTX780 to those of GTX580 
is about 2.7, the performance on GTX780 was about 3 times better than those on GTX 
580 in two calculation parts. It resulted from not only the arithmetic capacities but also 
the difference of the architectures between the two GPUs: Fermi and Kepler. Kepler is 
the newer architecture of nVidia GPUs. Kepler not only has the improved arithmetic 
capacity, but also eases the restriction on the memory usage to utilize the full performance 
of GPU. One of significant differences between two architectures is in the restriction for 
the number of registers per thread. A remarkable example is the calculation part of the 
intermolecular non-bonded energy term of MM. This function requires many parameters 
for MM and GB calculations like partial charges, equilibrated distances for Lennard-
Jones potential, etc. This increases the number of registers required for each thread: 45 
registers were needed for one thread to execute this kernel function. Under this restriction, 
only 37.5% of threads per multiprocessor can be executed concurrently on Fermi GPU. 
On the other hand, 56.2% of threads per multiprocessor can be executed concurrently on 
Kepler GPU. The number of the registers usually becomes the bottleneck for utilizing the 
full performance of GPU. Improvements on the number of available threads were 
observed in most kernel functions, and contributed to the accelerations beyond the ratio 
of the arithmetic capacities of the two GPUs. 
 
1.5.2. Prediction Accuracy of Binding Conformations 
Positional restraints significantly impacted on prediction accuracies of the binding 
conformations for the two programs, but implementations of the positional restraints are 
different in them. For our program, native docking scores (the docking score excluding a 
restraint term) were improved compared to those with no positional restraints. The 
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positional restraint acted like a guide, leading binding conformations to more stable ones. 
This result indicated that the search space occupied by the stable conformations was very 
small under our scoring function. Our program cannot find this space alone, but positional 
restraints can help it. 
By contrast, only subtle difference in native docking scores with or without 
positional restraints was observed in GOLD. For GOLD, the insufficient searching ability 
was not only the reason to predict the conformations having higher RMSD values. GOLD 
cannot distinguish the correct binding conformations in terms of the docking score. 
ChemPLP evaluates the binding conformations by the shape complementary and the 
formation of hydrogen bonds between the ligand and the receptor atoms. The shape 
complementary can be a good indicator for small molecules, because they have low 
internal degrees of the conformational freedom. It is difficult for small molecules to fit 
their conformations into the shape of the binding pocket of proteins. On the other hand, 
the high conformational flexibility of peptides permits to change their conformations to 
fit in anywhere in the binding site of proteins. In addition, the high conformational 
flexibility of peptides also allows to form many hydrogen bonds with receptor atoms. The 
scoring functions designed for small molecules may not make significant differences 
between binding conformations of peptides. 
We examined the binding conformations predicted using two programs by means of 
the rescoring of the binding affinities using MM energy functions. Table 1-4 shows the 
binding affinities of the top solutions of each docking run calculated by MM-GB (not 
including SA term) method. Obviously, our program predicted more stable conformations 
than GOLD. This result indicated that our program could detect the key interactions in 
the ligand-protein complex properly, but GOLD cannot. MM-based rescoring schemes 
were often used as a post process of the molecular docking [9, 30]. In this situation, the 
problems for selecting binding poses predicted by the molecular docking would arise. 
Typical programs for the molecular docking output several binding conformations of the 
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ligand molecule in each execution. Because there was no consistency between the 
docking scores and MM-based binding affinities, all binding conformations predicted by 
the molecular docking have to be evaluated by MM-based method to find the most stable 
conformations in terms of the MM. On the other hand, our program uses the potential 
energy of MM and GB as the scoring function in the molecular docking. This is the great 
advantage for our program to be able to find the stable conformations in terms of MM in 
the molecular docking, and to get the consistent results with the rescoring scheme. 
 
1.5.3. Computational Cost 
We showed the high performance of our program to predict stable conformations in 
previous subsections. However, our computational time was too long, though extreme 
acceleration by GPU has already been accomplished. The computational cost for 
intramolecular non-bonded energy term within receptor atoms is especially high, though 
these interactions are not calculated in ordinary docking program. However, we have to 
calculate them because GB was incorporated to our scoring function: the effective born 
radii of receptor atoms are changed according to the conformation of ligand molecule, 
and it results in the change of the GB energy of intramolecular interactions within receptor 
atoms. 
We could confirm the superiority of our scoring function in previous subsections. 
We have to make more efforts to reduce computational time while keeping the prediction 
accuracy of our scoring function. 
One approach is to neglect interactions between the ligand atoms and the receptor 
atoms far from the any ligand atoms. This is the similar approach to the conventional 
programs. We examined this approach using the GIP-peptide complex. At that time, only 
receptor atoms within 15 Å from any ligand atoms were used as an input structure. It 
resulted in computational time of 4m6s and retained the RMSD of 2.31 Å. This approach 
seems to be useful, but the influence from the receptor atoms unnaturally exposed to 
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solvents remains unknown. Another approach is more reasonable to exclude the 
interactions between the ligand atoms and distant receptor atoms from the calculations of 
the effective born radii, instead of removing the distant receptor atoms. This classifies the 
receptor atoms into two layers according to the distance from the binding interface. This 
treatment can neglect the calculations of effective born radii between ligand atoms and 
distant receptor atoms, and the calculations of intramolecular non-bonded energy term 
within distant receptor atoms. It would work effectively if the target protein is large and 
highly charged. 
An appropriate library design may compensate the deficiency of high computational 
cost of our program at another level. Because the number of combinations of amino acid 
sequences is numerous, the efficient enumeration of candidate peptides helps to reduce 
the computational time in total. Evolutional algorithm can be used to optimize amino acid 
sequences [31]. However, such optimization protocols are highly dependent on the 
prediction accuracy of the binding affinity. It is essential to use the accurate method for 
prediction of the binding affinity like the rescoring. 
 
1.5.4. Recommended Usage 
We describe the recommended usage of our program. First, our program requires the 
3D-structure of the receptor proteins. If available, it is preferred to use the equilibrated 
structures generated by MD simulations. Because our scoring function is based on the 
potential energy function on MM, the equilibrated structure optimized to MM is 
compatible with our scoring function. On the other hand, the structures determined 
experimentally are not optimized for MM. MD simulation is also helpful to find optimal 
conditions for positional restraints on the ligand molecule. The use of positional restraints 
is highly recommended for the accurate prediction. 
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1.6. Conclusion 
We demonstrated the high ability of our docking program to predict binding 
conformations of the ligand molecule. Although conventional docking program can also 
predict accurate binding conformations in terms of RMSD, only our program can predict 
stable conformations with the lower ΔMM-GB energy. MM-based predictions of the 
binding affinity are often used as a post process of the molecular docking. The consistency 
of the evaluation functions between the molecular docking and the post processes will be 
great advantages. On the other hand, our results revealed the limitation of conventional 
scoring functions for the molecular docking of peptides.  
We accomplished the acceleration of the molecular docking using GPU. We showed 
the good example of GPU-acceleration for not only MM-based functions but also for the 
functions utilizing the 3D coordinate system. These techniques are applicable to other 
molecular simulations like the homology modeling. This can enhance the usability of 
applications and encourage the research on computational molecular design. 
. 
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1.7. Figures 
 
 
Figure 1.1 Soft Lennard-Jones Potential 
Red line represents soft Lennard-Jones potential implemented in our scoring function. 
The standard 12-6 Lennard-Jones potential are represented by a blue dash line. 
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Figure 1.2 Flowchart of Procedures of Our Program 
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Figure 1.3 Flowchart of Calculation of Docking Score 
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1.8. Tables 
Table 1-1 Computational Time of each Calculation Part for Grb2 
Rates of computational time compared to CPU are listed in brackets. 
 
1 core of core 
i7 4770K 
GTX580 
(Fermi) 
GTX780 
(Kepler) 
Conversion of 3D 
Coordinates System 
288 ms 
2.2 ms 
(x130.9) 
1.5 ms 
(x189.5) 
Calculation of Distance 
Matrix (CPU only) 
42,829 ms - - 
Calculation of 
Dihedral potentials 
963 ms 
2.3 ms 
(x427.2) 
1.9 ms 
(x514.3) 
Effective Born Radii 
(within ligand atoms) 
3,626 ms 
47 ms 
(x76.0) 
16 ms 
(x224.2) 
Effective Born Radii 
(between ligand-receptor) 
54,964 ms 
910 ms 
(x60.4) 
471 ms 
(x116.7) 
Non-bonded Energy 
(within ligand atoms) 
2,030 ms 
41 ms 
(x49.3) 
17 ms 
(x117.8) 
Non-bonded Energy 
(within receptor atoms) 
207,645. ms 
1350 ms 
(x153.8) 
731 ms 
(x283.8) 
Non-bonded Energy 
(between ligand-receptor) 
44,865 ms 
416 ms 
(x107.8) 
135 ms 
(x332.4) 
Make Neighbor List 1607 ms 
152 ms 
(x10.5) 
111 ms 
(x14.5) 
Total Computational Time 359,576 ms 
3497 ms 
(x102.8) 
2053 msec 
(x175.2) 
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Table 1-2 Computational time of each Calculation Part for GIP 
Rates of computational time compared to CPU are listed in brackets. 
 
1 core of core 
i7 4770K 
GTX580 
(Fermi) 
GTX780 
(Kepler) 
Conversion of 3D 
Coordinates System 
293 ms 
2.4 ms 
(x122.1) 
1.6 ms 
(x179.5) 
Calculation of Distance 
Matrix (CPU only) 
52,244 ms - - 
Calculation of 
Dihedral potentials 
945 ms 
2.2 ms 
(x433.4) 
1.9 ms 
(x506.4) 
Effective Born Radii 
(within ligand atoms) 
3,730 ms 
49 ms 
(x76.4) 
17 ms 
(x224.5) 
Effective Born Radii 
(between ligand-receptor) 
67,520 ms 
1108 ms 
(x60.9) 
572 ms 
(x118.0) 
Non-bonded Energy 
(within ligand atoms) 
2,010 ms 
41 ms 
(x48.7) 
17 ms 
(x116.6) 
Non-bonded Energy 
(within receptor atoms) 
326,471 ms 
1941 ms 
(x168.2) 
1091 ms 
(x299.3) 
Non-bonded Energy 
(between ligand-receptor) 
57,153 ms 
502 ms 
(x114.0) 
161 ms 
(x355.1) 
Make Neighbor List 1626 ms 
155 ms 
(x10.5) 
114 ms 
(x14.3) 
Total Computational Time 512,753 ms 
4372 ms 
(x117.3) 
2554 ms 
(x200.2) 
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Table 1-3 Comparison of RMSD values for Pose Predictions 
P.R. off is RMSD values of the molecular docking without positional restraints. 
P.R. on is those with positional restraints. Constraint weight are listed in brackets for 
GOLD. 
min is those using minimized structure. 
MD is those using equilibrated structure by MD. 
 Crk Grb2 Src GIP 
 min MD Min MD min MD min MD 
Our Program        
P. R. off 5.45 15.50 10.69 19.2 16.09 9.66 10.48 10.68 
P. R. on 1.81 1.55 2.04 2.21 3.46 1.60 3.38 2.58 
GOLD 
        
P. R. off 10.11 11.15 4.55 7.43 5.93 11.45 19.28 16.16 
P. R. on(10) 2.39 1.89 2.14 2.31 9.29 10.88 2.84 13.95 
P. R. on(20) 1.95 1.69 2.40 2.59 6.78 3.29 2.45 2.40 
P. R. on(30) 1.93 1.86 2.32 2.37 3.18 2.16 2.94 2.19 
[Å] 
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Table 1-4 ΔMM-GB Energy of Top Solution 
ΔMM-GB energy were calculated after the energy minimizations of the top solution of 
the molecular dockings, where the receptor conformation is fixed. Positional restraints 
were applied on every molecular docking (constraint weight is 30 for GOLD). 
 Crk Grb2 Src GIP 
 min MD min MD min MD min MD 
Our Program -48.8 -80.0 -81.3 -101.7 -68.5 -96.0 -23.8 -35.9 
GOLD -37.9 -55.7 -89.2 -61.5 -58.5 -86.0 -11.4 -29.1 
[kcal/mol] 
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Chapter 2 
New Radii for 
Poisson-Boltzmann 
Implicit Solvent 
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2.1. Introduction 
The Poisson Boltzmann (PB) implicit solvent is commonly used to estimate the polar 
contribution of the solvation free energy of biological molecules. PB is used in the 
Molecular Mechanics and Poisson Boltzmann surface area (MM-PBSA) method [11], 
which estimates the free energy of the molecule in a solution. MM-PBSA is used to 
estimate the binding free energy (ΔGbind) of a ligand to a receptor molecule. ΔGbind is 
calculated as follows:  
Δ𝐺𝑏𝑖𝑛𝑑 = 𝐺𝑐𝑜𝑚 − (𝐺𝑟𝑒𝑐 + 𝐺𝑙𝑖𝑔) 
where Gcom, Grec, and Glig denotes the free energy calculated by MM-PBSA method using 
the complex, receptor-only, and ligand-only structure, respectively. MM-PBSA is applied 
over the trajectory generated by molecular dynamics (MD) simulations or to a single 
snapshot, e.g., a docked structure (rescoring) [9, 30]. Many researchers have successfully 
designed inhibitors of various proteins using MM-PBSA [10, 32]; however, the low 
accuracy of PB has been pointed out. In MM-PBSA, ΔGbind is expressed as follows: 
∆𝐺𝑏𝑖𝑛𝑑 = ∆𝐸𝑀𝑀 + ∆𝐺𝑃𝐵 + ∆𝐺𝑆𝐴 − 𝑇∆𝑆 
where EMM is the potential energy of MM in a gas phase; GPB, a polar contribution of the 
solvation free energy calculated by PB; GSA, a nonpolar contribution of the solvation free 
energy calculated by a surface-area based approach; T, an absolute temperature; and S, 
the entropy. GPB is calculated by solving the Poisson equation: 
∇ ∙ 𝜀(𝑟)𝜙(𝑟) = −4𝜋𝜌(𝑟) 
where r is a given position; ε(r), a dielectric constant at r; ϕ(r), an electrostatic potential 
at r; and ρ(r), a solute charge distribution at r.  
In this chapter, we discuss the dielectric boundary in PB solvents. The dielectric 
boundary defines a pseudo-volume of the solute. The dielectric constant at a given point 
is determined by whether this point is inside or outside the volume of the solute. Because 
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the result of PB is highly dependent on the distribution of dielectric constants, it is 
important to provide the appropriate definition of the dielectric boundary of the solute. 
Definitions based on the atomic radii have been well studied [33-36]. Sitkoff et al. 
developed PARSE radii to obtain an agreement between experimentally-determined 
solvation free energies and those calculated by PB using small organic molecules [33]. 
Tan et al. developed their PB radii to obtain agreement with the solvation free energy 
calculated using TIP3P explicit solvents. They used template molecules of amino-acid 
analogues and nucleic acids [36]. They designed atom-type specific radii using partial 
charges and atom types in AMBER force fields. Meanwhile, an abrupt and discontinuous 
transition of dielectric constants at the dielectric boundary causes large differences on the 
solvation free energy and the solvation forces between subtly different conformations. A 
smooth dielectric function alters the dielectric constants smoothly and continuously over 
the dielectric boundary [37, 38]. It can avoid large fluctuations of solvation free energies 
and forces; however, the smooth function also alters the optimal location of the dielectric 
boundary. An alternative set of atomic radii specific for the smooth dielectric function is 
then required. Im et al. introduced a spline-smoothed dielectric function [38]. Afterward, 
Swanson et al. developed PB radii [34, 35] specific for the smooth function developed by 
Im. Swanson et al. used template molecules of amino acids in the AMBER force field and 
parameterized PB radii to obtain agreement with the explicit solvent simulations using 
TIP3P waters. 
The PB methods developed by both Tan et al. and Swanson et al. were based on 
simulation results using TIP3P explicit solvents and defined using the AMBER force field. 
This means that the two methods should provide consistent results for the solvation free 
energy; however they do not (Figure 2.3). From the differences between their methods 
for development of the PB radii set, we propose the reasons why their methods provide 
the different results. One is the difference between the boundary conditions of the explicit 
solvent simulations. Tan et al. used the periodic boundary condition with the Particle 
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Mesh Ewald (PME) method [39], whereas Swanson et al. used the spherical boundary 
with the spherical solvent boundary potential (SSBP) [40]. SSBP was used to approximate 
the influence of the bulk waters surrounding the spherical cap. Under the periodic 
boundary condition with PME, the net charge of the system must be zero. In the usual 
case, the system is neutralized by adding several ions with an opposite charge to the solute. 
In this case, however, any ions cannot be added to the system in order to calculate the 
solvation free energy and forces in pure waters. This results in the modification of the 
partial charges of the solute, if the solute has non-zero net charge. This effect must be 
carefully considered in the simulation results. On the other hand, under the spherical 
boundary condition, we have to consider the influence of abnormal distributions of waters 
at the edge of the solvent cap, even though SSBP is applied. 
Here, we present results concerning the system-size dependence of the solvation free 
energies under the different boundary conditions (Table 2-1). We used one conformation 
of an N-terminal lysine (NLYS) as a template molecule because of its net charge (+2): the 
distribution of waters strongly influences the solvation free energy of NLYS. Table 2-1 
indicates the system-size dependence of solvation free energies for the spherical boundary 
condition, and the system-size independence for the periodic boundary condition. Figure 
2.1 indicates the system-size dependence for the spherical boundary through another 
observation. Figure 2.1 shows the radial solvent charge distribution around a Cα atom of 
NLYS calculated with solvent caps of various sizes. The peak shapes around 5 Å are 
similar to each other. We observe bulk-like distributions of waters beyond 10 Å in every 
graph and also unnatural peaks around each edge of water spheres. It suggested that these 
unnatural peaks caused the difference between the free energies for different system sizes. 
Therefore, the results of the explicit solvent simulations using the spherical boundary are 
less reliable. Likewise, the PB radii optimized by Swanson et al. are also less reliable. 
These influences are more remarkable for charged molecules (Figure 2.3). On the other 
hand, we observe the system-size independence of the solvation free energies of NLYS 
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for the periodic boundary condition. However, how neutralizing treatments influence the 
free energies of larger molecules remains uncertain. 
The selection of template conformations to parameterize PB radii is also important. 
Tan et al. and Swanson et al. parameterized their PB radii using amino-acid-based 
molecules. Swanson used dipeptides of each non-terminal amino acid and several poly-
alanines to consider the secondary structures of proteins, but the N- and the C-terminal 
amino acids were not included in the templates. We were forced to assign PB radii of non-
terminal residues to terminal residues, although a large difference in solute-solvent 
interactions is expected. On the other and, Tan et al. used three dipeptides of alanine, 
proline, and glycine for backbone atoms. They also used the side-chain analogues of each 
amino acid for side chain atoms. Their PB radii were parameterized without 
considerations of the existence of backbones and side chains between one another. In 
addition, they did not consider the secondary structures of proteins. 
In this chapter, we propose new PB radii for the accurate estimation of the polar 
contribution of the solvation free energy. Our work was based on the considerations of 
the previous studies described above. We parameterized our PB radii to obtain agreement 
with the explicit solvent simulations using TIP3P solvents. We used the spherical 
boundary condition for explicit solvent simulations. A special cut-off scheme was applied 
only to the calculation of the solvation free energy. It enabled us to exclude the influence 
of the abnormal distribution of waters on the edge of the spherical boundary. 
Furthermore, we reduced excessive atom-type grouping in assignments of PB radii. 
In previous studies, all atoms in amino acids were grouped into several atom types. 
Groups were determined according to their physiochemical characteristics such as the 
radial solvent charge distribution around each atom. Identical PB radii were assigned to 
atoms in the same groups. Atom-type grouping is useful for enhancing compatibility 
between multiple conformations. However, atoms with the same PB radius but different 
partial charges may cause significant errors in the PB results owing to the sensitivity of 
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the PB calculations. In our work, we grouped only backbone atoms of non-terminal 
residues. Instead, we increased the number of template conformations of each amino acid 
to maintain the compatibility between various conformations. 
In this chapter, we first present our parameterization of PB radii using a training set. 
Next, we measure the performance of our PB radii beyond the training set: we examined 
the prediction accuracy using larger molecules in a test set, and evaluated the prediction 
performance of the binding affinities by MM-PBSA method. 
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2.2. Methods 
2.2.1. Atom-Type Grouping 
We designed our PB radii specific for the AMBER protein force field (ff99SB or 
later) [18]. We assigned common PB radii only to each N, H, C, and O atom forming a 
peptide bond on each amino acid. They could be classified into several groups according 
to the charge states of the side chain atoms and terminal ends of the backbone atoms. 
Because terminal residues does not associate with the formation of secondary structures 
of proteins, we assigned common radii only to atoms in non-terminal residues. Thus, the 
PB radius of each N, H, C, and O atom consists of four patterns: three were determined 
by the charge states of the side chain of each amino acid, and the other is for an 
exceptional residue, a proline.  
Each particular PB radius was assigned to all of the other atoms. 
 
2.2.2. Training Set 
All of our PB radii were parameterized using molecules in a training set. We first 
optimized PB radii using 12 poly-alanines used in Swanson’s work. Poly-alanines include 
atoms forming the peptide-bond in non-terminal and non-charged amino acids and atoms 
in protein caps. In other words, we took account of secondary structures of proteins only 
for atoms forming the peptide-bond in non-charged amino acids. The structures of poly-
alanines were prepared as follows: specific regions of proteins were extracted from PDB 
entries, 1AKI [41] and 1EJG [42]. Both the N-terminal and C-terminal ends of backbones 
were capped with N-acetyl (ACE) and N-methyl amide (NME) groups. Then, all amino 
acids were mutated to alanines. Energy minimizations were carried out in the box of 
TIP3P waters. After minimizations, all solvents and ions were removed. 
Next, we parameterized the PB radii of atoms in each amino acid using multiple 
conformations as templates. Most conformations were selected from trajectories of MD 
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simulations. In addition, to increase sampling efficiency, conformations generated by 
systematic conformational search implemented in MOE [43] were used as necessary. 
Molecular simulations were carried out as follows: all non-terminal ends of the backbone 
of amino acids were capped with ACE and NME groups. After soaking solutes in the box 
of TIP3P waters, we generated 10 ns MD trajectories at 310 K using the pmemd module 
of AMBER [24]. Then, clustering analysis was performed to obtain the representative 
conformations of each molecule. Some of them were selected as template conformations. 
A systematic conformational search was carried out with the generalized born implicit 
solvent [16], and additional conformations were selected manually. Finally, all template 
conformations were energetically minimized in the box of TIP3P waters. Details of the 
number of conformations of each amino acid are illustrated in Figure 2.4 - Figure 2.6. 
 
2.2.3. Test Set 
To measure the performance of our PB radii beyond the training set, we used 23 
structures of 13 peptides of various lengths and compared with the solvation free energies 
calculated by the explicit solvent simulations. We selected experimentally determined 
structures of 13 peptides, and downloaded from the PDB web site [19]. Detailed 
information of these molecules are listed in Table 2-2. The other 10 conformations were 
a wide variety of conformations of Chignolin generated by Replica Exchange MD [44] 
with the generalized born solvent from PDB entry 1UAO [45]. All conformations were 
energetically minimized in the box of TIP3P waters.  
 
2.2.4. MM-PBSA Test 
Our objective is to improve the accuracy of in silico screening based on the MM-
PBSA method regardless of whether MD trajectories or single snapshots are used. We 
used experimental data of systematic alanine-mutational analysis of PMI peptides with 
MDM2 protein [46, 47]. We selected 12 peptides of the same length from experimental 
- 53 - 
 
data and estimated the binding affinities by MD trajectory-based MM-PBSA.  
We calculated the binding affinity ΔGbind by MM-PBSA in two manners: “one 
trajectory method” and “two trajectory method”. The one trajectory method is the simple 
and standard application of MM-PBSA in which MD simulation is performed only for 
the complex structure. The structures of the receptor and ligand molecule are extracted 
from the complex structure from each snapshot of the complex structure. In the one 
trajectory method, ΔGbind is calculated as follows: 
Δ𝐺𝑏𝑖𝑛𝑑 = 𝐺𝑐𝑜𝑚 − (𝐺𝑟𝑒𝑐,𝑏𝑜𝑢𝑛𝑑 + 𝐺𝑙𝑖𝑔,𝑏𝑜𝑢𝑛𝑑) 
where Gcom is the free energy calculated using the complex structure from the MD 
trajectory, and Grec,bound and Glig,bound are the free energies calculated using the receptor 
and the ligand structures extracted from the complex structure, respectively. On the other 
hand, the two trajectory method uses additional MD trajectories of the ligand molecules 
in the unbound state. In the two trajectory method, ΔGbind is calculated as follows: 
Δ𝐺𝑏𝑖𝑛𝑑 = 𝐺𝑐𝑜𝑚 − (𝐺𝑟𝑒𝑐,𝑏𝑜𝑢𝑛𝑑 + 𝐺𝑙𝑖𝑔,𝑢𝑛𝑏𝑜𝑢𝑛𝑑) 
where Glig,unbound is the free energy calculated using the ligand structure from the MD 
trajectory in the unbound state. We compared the performances of our PB radii for two 
MM-PBSA methods. 
All MD simulations were carried out as follows: the 3D structure of MDM2 and a 
N8A mutated PMI peptide complex was downloaded from the PDB web site (PDB ID: 
3LNZ) [46]. The 3D structure of an unmutated peptide and MDM2 complex was 
predicted by a homology model module implemented in MOE. The complex structures 
with all other mutated peptides were generated by removing atoms in the side chain of 
relevant residues. Structures of PMI analogues in the unbound state were extracted from 
each complex structure. All solutes were soaked in the cube box of TIP3P waters and 
energetically minimized. We carried out 10 ns MD simulations for equilibration and 15 
ns ones for production runs at 300K. Snapshots were sampled every 10 ps in the 
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production run. MM-PBSA was performed using these snapshots. Receptor atoms far 
from the binding interface were harmonically restrained at their initial positions with a 
force constant of 10 kcal/mol/Å2 during MD simulations. Entropic contributions were not 
included in these calculations. All MD simulations were executed by the pmemd module 
of AMBER 12.  
 
2.2.5. Explicit Solvent Simulations 
We used the thermodynamic integration (TI) method [23] to estimate the polar 
contribution of the solvation free energy of the solute with TIP3P explicit solvents. We 
used 15 lambda points to scale the electrostatic interactions between the solute and the 
solvents. All lambda values were derived from the Gaussian quadrature equation. Initial 
structures were set up by locating the solute at the center of a spherical cap of TIP3P 
waters. The radius of the solvent cap for the training set and the test set was 45 Å and 53 
Å, respectively. All atoms of the solute were harmonically restrained at their initial 
positions with a force constant of 50 kcal/mol/Å2. We ran 15 MD simulations with the 
same initial coordinates but different lambda values. We performed 500 ps MD simulation 
for equilibration and another 500 ps one for the production run at 300 K at each lambda 
point. No cut-off schemes were employed for MD runs. Snapshots were sampled every 
20 fs in the production run and a total of 25,000 snapshots of each lambda point was used 
for calculating the solvation free energy. To remove the influence of an abnormal 
distribution of waters at the edge of the solvent sphere, we employed a cut-off scheme in 
the calculation of the free energy. Because a simple scheme using a single cut-off distance 
results in the large fluctuation of the calculated free energy, we set multiple cut-off 
distances over a given range with a desired step size and averaged the calculated free 
energies at each cut-off distance. The cut-off distances ranged from 25 to 30 Å and from 
28 to 33 Å for the training set and the test set, respectively. We observed the behaviors of 
bulked waters in these ranges of radial solvent charge distribution functions. The step size 
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was 0.1 Å. 
We also calculated the polar solvation forces using the TIP3P waters. As described 
by Wagoner [48], a polar term of the solvation force Fp is represented by: 
𝐹𝑝 = 𝐹𝑝+𝑛𝑝̅̅ ̅̅ ̅̅ ̅̅ − 𝐹𝑛𝑝̅̅ ̅̅ ̅ 
where 𝐹𝑛𝑝 is an averaged force acting on each atom in the solute over an ensemble 
where only nonpolar interactions between the solute and the solvents are worked 
(electrostatic interactions are off), and 𝐹𝑝+𝑛𝑝̅̅ ̅̅ ̅̅ ̅̅  is an averaged force where full 
interactions between the solute and the solvents are worked. Thus, we carried out two 
MD simulations with full- and zero-charges of the solute. The simulation condition was 
the same as that for the solvation free energy except for the solute charges. 
All explicit solvent simulations were carried out using AMBER 10 modified for use 
on the special-purpose computer MD-GRAPE3 [49]. 
 
2.2.6. Implicit Solvent Simulations  
Our implicit solvent calculation was based on Swanson’s work. We solved the non-
linear Poisson-Boltzmann equation using the Adaptive Poisson-Boltzmann Solver (APBS 
version 1.3) [50]. The spacing of a PB grid was 0.20 Å. The number of grid points in each 
dimension was determined to become more than 10 Å larger than the size of solutes. 
Solute charges were distributed to PB grids using a cubic B-spline discretization. The 
dielectric functions were calculated by the smooth functions developed by Im et al. [38] 
with a half window of 0.3 Å. The dielectric constant inside and outside the solute was 1.0 
and 78.4, respectively. The probe size of water was 1.4 Å. To reduce the dependence on 
the orientation of the solute to the grid, we prepared another orientation of each solute 
and averaged each result. We calculated the per-atom solvation free energy and forces, 
and compared them with explicit ones. 
We compared the performance of our PB radii with three other implicit solvents that 
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are commonly used with the AMBER force field. The generalized born (GB) implicit 
solvent model is most common for molecular simulations. We employed the OBC model 
of GB [17] using AMBER 12. The dielectric constant inside and outside the solute was 
1.0 and 80.0, respectively. The probe radius of water was set to 1.4 Å. The other two 
methods were Tan’s and Swanson’s methods described above. Tan’s PB was carried out 
using an mm_pbsa.pl script of AMBER 12. The dielectric constant was the same as in the 
GB calculation, but the probe size of water was 1.6 Å. The grid spacing was set to 0.333 
Å. Swanson’s method was carried out using APBS program. Swanson’s method used the 
same condition as ours. 
 
2.2.7. Optimization of PB Radii 
We optimized our PB radii using a genetic algorithm (GA) to obtain good agreement 
between the implicit and the explicit solvents. We first searched for an optimal 
combination of PB radii in poly-alanines and, next, we searched for those of each amino 
acid. The PB radii were optimized to minimize a fitness function, f. 
𝑓 = ∑ 𝑓𝑖
𝑐𝑜𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑖
 
where fi is a fitness score of each conformation of optimized amino acids. We defined fi 
as follows: 
𝑓𝑖 = 𝑅𝑀𝑆(∆𝐺𝑃𝐵,𝑟𝑒𝑠𝑖𝑑𝑢𝑒) + 𝑎𝑅𝑀𝑆(∆𝐺𝑃𝐵,𝑎𝑡𝑜𝑚) + 𝑏𝑅𝑀𝑆(∆𝐹
𝑝) 
where ∆𝐺PB,r𝑒𝑠𝑖𝑑𝑢𝑒 and ∆𝐺PB,a𝑡𝑜𝑚 are errors of the polar contribution of the solvation free 
energy between implicit and explicit solvents on a per-residue and per-atom basis, 
respectively. ∆𝐹𝑝 is the error of polar solvation forces for each dimension of each atom. 
We incorporated atom-based and residue-based terms to reduce the dependence of the PB 
radii on amino acid sequences. a and b are scaling factors for each component. Scaling 
factors 𝑎 and b were set to 0.5 and 1.0, respectively. The parameters of GA are as follows: 
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the population size is 600. The gene is represented as the combination of PB radii. Initial 
combinations were determined by random numbers. The PB radii were optimized by 
using genetic operators: an uniform crossover and a single-point mutation. The rate of the 
crossover and the mutation operator is 0.7 and 0.3 respectively. The step size of the 
mutation operator is 0.01. Five new genes were generated from each of 600 genes, and a 
gene having the best fitness score becomes the gene in the next iteration. 
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2.3. Results 
2.3.1. Explicit Solvent Simulations 
    We first validated our protocol of the explicit solvent simulation. Figure 2.2 shows 
the relation between the solvation free energy of a C-terminal asparaginic acid (CASP) 
and the cut-off distance applied to the calculation of the free energy. We also compared 
those characteristics between spherical caps of waters of different sizes. We observe 
almost perfect agreement between the free energies for different sphere sizes except for 
regions around the edge of each water sphere. The free energies around 20-30 Å are very 
similar in different sphere sizes but fluctuated. This is why multiple cut-off distances were 
used in this study. The free energies calculated using the multiple cut-off scheme show 
good agreement between solvent caps of different sizes (Table 2-3). We also observed 
different free energies between solvent caps of different sizes when using an infinite cut-
off distance.  
  Similar results were obtained for the N-terminal lysine mentioned in the introduction 
of this chapter (Table 2-1). It is important for our averaged free energy to be consistent 
with the free energies calculated under the periodic boundary condition. This result 
provided strong evidence to support the validity of our explicit solvent simulations. 
We also performed additional 500 ps MD for the production (total of 1000 ps) at 
each lambda point on the sphere size of 45 Å and obtained the free energy of -270.3 
kcal/mol (standard error was ±1.03 kcal/mol). There was little difference between the 
calculated free energies for different time lengths of production runs. This result 
confirmed that our simulation time was long enough for convergence. This was expected 
because our simulation times were several times longer than those of previous studies. 
 
2.3.2. Performance on Training set 
The statistical performances of our PB method and the other implicit solvents on 
molecules in the training set are listed in Table 2-4 (a). From this table, it is indicated that 
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both the average of the absolute errors and the root mean square errors of our PB method 
are quite small, which means that our optimization of PB radii using GA was successfully 
accomplished. (It should be noted that we cannot compare these values with other implicit 
solvents because our PB radii were designed to minimize these values.) Figure 2.3 shows 
comparison between the polar contribution of solvation free energies of molecules in the 
training set calculated by explicit and implicit solvents. All implicit solvents had strong 
correlations with explicit solvents where the correlation coefficients of all implicit 
solvents were more than 0.99; however, other implicit solvents tended to have low 
accuracies in some particular types of molecules (Figure 2.4-Figure 2.6). GB tended to 
overestimate the solvation free energy in most molecules, and most of these errors were 
the largest, except for negatively charged amino acids. Tan’s method tended to 
underestimate the solvation free energy of molecules in the training set, but showed good 
performances for charged amino acids. In addition, Tan’s method had relatively low 
accuracy for poly-alanines considering their low polarities. Swanson’s method had 
significant errors for charged molecules, especially for both N- and C-terminal amino 
acids. Swanson’s method tended to underestimate the solvation free energy for negatively 
charged molecules and to overestimate those for positively charged molecules. All the 
other implicit solvents had problems with regard to the estimation accuracy of the polar 
contribution of the solvation free energy. 
 
2.3.3. Performance on Test set 
We measured the performances of our PB method and other implicit solvents beyond 
the training set using larger molecules in the test set. Our PB method showed high 
estimation accuracies of solvation free energies of molecules in the test set (Table 2-4 (b) 
and Figure 2.7). On the other hand, other implicit solvents had strong correlations with 
explicit solvents, but large errors of solvation free energies were observed. GB tended to 
overestimate the solvation free energies in most molecules. However, GB seems to have 
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good accuracies for 11 conformations of Chignolin: the averaged absolute errors of 
solvation free energies was 2.28 kcal/mol and the root mean square errors was 1.33 
kcal/mol. GB certainly had good agreements with explicit solvents for the total solvation 
free energy, but errors in the solvation free energies on a per-residue basis were quite large. 
The fact suggests that the fairly accuracy of GB for Chignolin was due to an accidentally 
good balance between the overestimated and the underestimated solvation free energies. 
GB was useless for obtaining details of the solvation free energies at the residue-level. 
Swanson’s method also had large errors on a per-residue basis. It tended to overestimate 
the free energies for positively charged molecules and to underestimate those for 
negatively charged molecules. Tan’s method underestimated the free energies of all 
molecules. For all PB methods, the errors of solvation free energies on a per-residue basis 
were similar to those of the training set, but large root mean square errors were observed 
(Figure 2.8 - Figure 2.10). 
 
2.3.4. Performance on MM-PBSA 
Table 2-5 lists the binding free energies of 12 MDM2-peptide complexes calculated 
by the one trajectory method of MM-PBSA using various implicit solvents. Figure 2.11 
shows the comparison between the calculated and the experimental binding free energies 
of 12 peptides to MDM2. The shifts of absolute calculated binding free energies occurred 
between different implicit solvents, but the relative binding free energies (compared to 
unmutated TSFAEYWNLLSP peptide) were similar to each other, especially for 
Swanson’s method and our method. These two methods were the same except for the PB 
radii, and therefore, they tended to show similar binding free energies. The good 
correlations between calculated and experimental binding affinities were observed for all 
MM-PBSA method. Our method had subtly higher prediction accuracy of the binding 
affinities of 12 peptides in terms of the correlation coefficient. 
Table 2-6 lists the binding free energies of 12 MDM2-peptide complexes calculated 
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by the two trajectory method of MM-PBSA with various implicit solvents. Figure 2.12 
shows the comparison between the calculated and the experimental binding affinities. In 
the two trajectory method, large differences in the relative binding free energies of each 
peptide were observed as contrasted with the one trajectory method. Quite differences 
between Swanson’s and our PB method were also observed in ASFAEYWNLLSP and 
TAFAEYWNLLSP. Large differences were also observed in the correlation coefficients 
between MM-PBSA methods. The MM-PBSA method using our PB radii had best 
prediction performance for binding affinities, but correlation coefficients decreased in all 
MM-PBSA methods compared to those in the one trajectory method. 
 
 
 
  
- 62 - 
 
2.4. Discussions 
2.4.1. Performance of Our PB Radii 
Swanson’s method was inconsistent with the solvation free energy of charged 
molecules calculated by explicit solvent simulations. This was caused by the improper 
boundary conditions of the explicit solvent simulations. On the other hand, Tan’s method 
shows good accuracies for charged residues including N- and C-terminal residues. 
However, Tan’s method has lower accuracies as the length of peptides increases. This 
may be caused by insufficient selections of template molecules. Considerations of the 
secondary structures of proteins greatly affected to the accuracy of larger molecules. Our 
method could solve these problems by designing new PB radii. Our method showed the 
best performances for both estimations of the polar contribution of the solvation free 
energies of single molecule and of the binding free energies with MM-PBSA methods. 
Our method may be further improved by adding other template conformations. To 
improve the estimation accuracy, it is necessary to increase the number of template 
conformations according to the number of rotatable bonds in the side chain of each amino 
acid. For example, we observed relatively lower accuracy for the solvation free energy of 
methionine in the test set. Methionine has many rotatable bonds, but only three template 
conformations were included in our training set. Only three conformations cannot cover 
various conformations of methionine. Therefore, adding other conformations is expected 
to improve the accuracy of our PB method. 
 
2.4.2. Limitation of Modification of PB radii 
We observed great differences between Swanson’s and our PB radii. A typical 
example of these differences is the PB radius of the Cα atom in the backbone of amino 
acids. Our average PB radius of the Cα atom in non-terminal, N-terminal, and C-terminal 
amino acids is 2.428 Å, 2.827 Å and 1.431 Å, respectively. On the other hand, Swanson 
assigned a common PB radius of 2.353 Å and 2.428Å for the Cα atom of glycine and all 
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other amino acids, respectively. Because the PB radii represent the distances to the 
solvent-accessible surface, it is considered that atoms having large PB radii interact less 
with solvent molecules and atoms having small PB radii interact strongly with solvent 
molecules. Considering the results of Swanson’s method, where overestimations for 
positively charged molecules and underestimations for negatively charged molecules of 
the solvation free energies occurred, our PB radii of the Cα atoms were quite reasonable. 
Our PB radii provide an opportunity to consider the limitations of current PB 
methods. Too large or too small PB radii may work well in simple molecules such as 
those in our training set, but it is unknown how they would influence the solvation free 
energies of more complicated and larger molecules. Too small PB radii are especially 
problematic because they tend to generate small gaps in the interior of molecules. These 
gaps are regions having high dielectric constants, but they are not accessible by the 
explicit waters. It is easy to expect that these gaps cause errors in the calculated solvation 
free energies. In addition, small gaps increase the dependence of the free energy on the 
orientation of the solute to the PB grid. This is because wide grid spacing is insufficient 
to describe the distributions of dielectric constants around atoms having a small PB radius. 
We observed the fluctuation of the calculated solvation free energies between different 
orientations of the molecules in our training set to PB grid. A finer grid spacing is required 
to describe the small gaps well, but this increases the computational costs of PB 
calculations and requires a large amount of memory space on the computer resource. This 
is therefore no longer suitable for practical use. For these reasons, errors in the solvation 
free energy can be corrected to only a limited extent by modifying PB radii. Other 
approaches dealing with interactions between the charged moiety of the solute and 
solvents properly must be further studied. 
 
2.4.3. Toward Further Improvement of MM-PBSA 
In the one trajectory method of MM-PBSA, we observed similar relative binding 
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free energies for each peptide (Table 2-5). This seems to be caused by the cancellation of 
the errors in the solvation free energies of each complex, receptor, and ligand molecule 
in the calculations of the binding free energies. On the other hand, there were large 
differences in the binding free energies of each peptide calculated by the two trajectory 
method of MM-PBSA (Table 2-6). In the two trajectory method, these cancelling effects 
were decreased by half. The differences between implicit solvents were well reflected to 
the binding free energies. 
Although the one trajectory method provides a rougher approximation of the process 
of the ligand binding, its correlation coefficients are higher than those of the two trajectory 
method. One plausible explanation for this result is that errors in the one trajectory method 
are consistent with some contributions of the binding free energy lacking in the one 
trajectory method such as entropic contributions. This must be a special case for MDM-
peptide complexes; it does not always work well in other protein-ligand complexes. 
Nevertheless, the one trajectory method still remains the standard protocol of MM-PBSA. 
Our results revealed one reason for this: poor implicit solvents produce additional errors 
in the two trajectory method. Our results indicated that accurate implicit solvents showed 
good estimation accuracy for the binding free energy in the two trajectory method, but 
they create the need to describe lacking contributions of the binding free energies more 
precisely, e.g., entropic contributions. We did not include the entropic contribution from 
the normal mode calculation [51] in this study because of their large deviations. It is 
obvious that the protocol of normal mode calculations implemented in AMBER has a 
problem in an energy-minimization scheme. Recently, an improved method for the 
energy-minimization scheme in normal mode calculations was published [52]. It is worth 
applying this method to our studies. Furthermore, intermediate waters are also sources of 
errors in MM-PBSA calculations. We often observed in some receptor-ligand complexes 
that waters went into an interspace between ligand and receptor atoms and resulted in 
overestimated binding free energies. This will be more problematic when long MD 
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simulations are carried out, because the chances for waters to go into the interspace are 
increased. Although long MD simulation should be needed for the more precise 
description of biological processes, it results in producing the errors in MM-PBSA 
calculations. Often, more realistic treatments are problematic for MM-PBSA calculations. 
However, we believe these treatments are required for accurate estimations of binding 
free energies available for a wide range of protein-ligand complexes in the future. Our 
accurate PB radii are one of the steps toward that final goal. 
Finally, we add some considerations of the LR MM-PBSA method [53]. The LR 
MM-PBSA method is one of the modified MM-PBSA methods. This method adjusts the 
magnitudes on each component of MM-PBSA (bonded, electrostatic, and van der Waals 
terms for the EMM, EPB, and ESA terms) by the use of scaling factors. The original purpose 
of LR MM-PBSA is to force the calculated binding affinities to be consistent with 
experimental binding free energies. A similar strategy may be useful for correcting 
imbalances between the implicit and the explicit solvation free energies for previous PB 
solvents. However, this attempt ended unsuccessfully in our study. Significant 
improvements in correlations were not observed in all MM-PBSA methods. LR MM-
PBSA will be useful only when similar ligand molecules are compared, because the 
optimal scaling factor is different according to the physiochemical characteristics of 
ligand molecules. Because peptides change their characteristics easily by the replacement 
of just one amino acid, LR MM-PBSA method would not be effective for peptide-protein 
complexes.  
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2.5. Conclusion 
We developed novel PB radii set to improve the estimation accuracy of Poisson 
Boltzmann implicit solvents. The use of our PB radii showed the good accuracies of 
estimations of the solvation free energies on single peptide molecules. The accuracy 
maintained stable if the length of amino acid residues of peptides was up to 24. 
Unfortunately, we cannot examine the performances on larger molecules, because the 
explicit solvent simulations cannot be performed due to the limit of computational 
memory. However, it is expected that our PB will show better performances than other 
implicit solvents. 
In the one trajectory method of MM-PBSA, the use of our PB radii set showed the 
best performance although the correlation coefficients between calculated and 
experimental binding free energies were similar in different MM-PBSA protocols. This 
is because a large portion of the errors in the solvation free energies were canceled in 
binding affinity calculations. In the two trajectory method of MM-PBSA, only the MM-
PBSA method using our PB radii set showed high estimation performances for the 
binding free energies. The two trajectory method also revealed inaccuracies of 
conventional implicit solvents. To improve the accuracy of MM-PBSA methods, more 
precise descriptions of other components such as entropies are also required in addition 
to our PB radii set. 
Our PB radii showed the limitation of optimizing the PB radii for accurate estimation 
of the solvation free energy. A too small radius on negatively charged groups tends to 
generate small gaps between solute atoms, which would cause the errors of the solvation 
free energy. Other approaches must be studied to describe appropriate interactions 
between the solutes and the solvents involved in charged moieties. 
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2.6. Figures 
 
 
Figure 2.1 Radial Solvent Charge Distributions for Solvent Caps of Various Sizes 
Radial solvent charge distributions around a Cα atom of an N-terminal lysine are 
calculated from explicit solvent simulations using solvent caps of different sizes (r: sphere 
radius). 
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Figure 2.2 Calculated Free Energy vs. Cut-off Distance 
The graph illustrates the relation of the polar contribution of the solvation free energy of 
a C-terminal asparaginic acid and the cut-off distance. We calculated the free energy with 
spherical water caps of different sizes. 
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Figure 2.3 Comparison between Implicit and Explicit Solvent in Training Set 
The relation of the polar contribution of the solvent free energy between explicit and 
implicit solvents model are illustrated as follows: 
Circles: non-terminal amino acids. 
Triangles: N- or C- terminal amino acids. 
Filled marks: non-charged amino acids. 
Blank marks: charged amino acids. 
x-marks: poly-alanines. 
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Figure 2.4 Errors in Solvation Free Energy per Residue (Training Set, Non-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for non-terminal residues in the training set. The number of 
residues included in molecules is listed in parentheses. 
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Figure 2.5 Errors in Solvation Free Energy per Residue (Training Set, N-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for N-terminal residues in the training set. The number of 
residues included in molecules is listed in parentheses. 
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Figure 2.6 Errors of Solvation Free Energy per Residue (Training Set, C-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for C-terminal residues in the training set. The number of 
residues included in molecules is listed in parentheses. 
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Figure 2.7 Comparison between Implicit and Explicit Solvents in Test Set 
The relation of the polar contribution of the solvent free energy between explicit and 
implicit solvents model is illustrated as follows: 
Circles: 12 different peptides 
Triangles: 11 conformations of Chignolin (including a pdb structure) 
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Figure 2.8 Errors of Solvation Free Energy per Residue (Test Set, Non-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for non-terminal residues in the test set. The number of 
residues included in molecules is listed in parentheses. 
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Figure 2.9 Errors of Solvation Free Energy per Residue (Test Set, N-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for N-terminal residues in the test set. The number of residues 
included in molecules is listed in parentheses. 
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Figure 2.10 Errors of Solvation Free Energy per Residue (Test Set, C-terminal 
Residues) 
Averaged errors of the polar contribution of the solvation free energy on a per-residue 
basis ΔGPB,residue [kcal/mol] for C-terminal residues in the test set. The number of residues 
included in molecules is listed in parentheses. 
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Figure 2.11 Performance on MM-PBSA using One Trajectory Method 
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Figure 2.12 Performance on MM-PBSA using Two Trajectory Method 
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2.7. Tables 
Table 2-1 Dependence of Solvation Free Energy on System Size 
Polar contributions of the solvation free energies calculated by each method are listed. 
An N-terminal lysine is used as a template. Simulation protocol of “Spherical Boundary” 
and “Periodic Boundary” was based on Swanson’s paper [35] and Tan’s paper [36], 
respectively. 
Spherical Boundary (Swanson) 
sphere radius (Å) 15 20 25 30 
solvation free energy (kcal/mol) -185.88 -186.78 -187.11 -187.45 
 
Periodic Boundary (Tan) 
length of each edge (Å) 50 60 70  
solvation free energy (kcal/mol) -168.12 -167.73 -167.74  
 
Our Method: Spherical Boundary with Infinite Cutoff Scheme 
sphere radius(Å) 20 30 40 45 
solvation free energy (kcal/mol) -159.53 -169.37 -174.52 -176.37 
 
Our Method: Spherical Boundary with Multiple Cutoff Scheme 
sphere radius(Å)   40 45 
solvation free energy (kcal/mol)   -168.04 -168.00 
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Table 2-2 Information of Molecules in Test Set  
Protein Name 
PDB 
ID 
Length Sequence Reference 
Met-enkephalin 1PLW 5 YGGFM [54] 
A fragment of 
ribonucleotide reductase 
1AFT 7 Ac-FTLDADF [55] 
Angiotensin II 1N9V 8 DRVYIHPF [56] 
Histon H3 analogue 1CS9 9 CGGIRGERA [57] 
Chignolin 1UAO 10 GYDPETGTWG [45] 
Designed peptide 2O0S 12 YVLWKRKRMIFI [58] 
A fragment of 
staphylococcal nuclease 
2FXZ 13 KMVNEALVRQGLA [59] 
mab198 bound peptide 2JRV 15 PMTLPENYFSERPYH [60] 
GCN4 trigger peptide 2OVN 17 
NYHLENEVARLKKLV 
GE 
[61] 
Designed peptide 2DX4 18 
INYWLAHAKAGYIVH 
WTA 
[62] 
TRP-cage 1L2Y 20 
NLYIQWLKDGGPSSG 
RPPPS 
[63] 
Phosphopeptide P140 
(non-phosphorylated form) 
2L5I 21 
RIHMVYSKRSGKPRG 
YAFIEY 
[64] 
Prion protein 1OEI 24 
HGGGWGQPHGGGWGQ 
PHGGGWGQP 
[65] 
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Table 2-3 Polar Solvation Free Energy Calculated by Our Method 
Radius of  
Spherical Cap 
Calculated Free Energies [kcal/mol] 
Infinite Cut-off Distance 
Multiple Cut-off Scheme 
(Range) 
40Å -232.35 
-271.16 ± 1.12 
(20-25 Å) 
45Å -232.99 
-270.32 ± 1.86 
(25-30 Å) 
50Å -235.31 
-271.42 ± 1.56 
(25-30 Å) 
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Table 2-4 Statistical Performance of Implicit Solvents 
Averaged absolute error (AAE) and the root mean square errors (RMSE) of the polar 
contribution of the solvation free energies between implicit and explicit solvents are listed. 
RMSE of polar solvation forces are listed. 
(a) Performance on training set molecules 
Implicit Solvents 
AAE and RMSE of 
Solvation Free Energy  
[kcal/mol] 
RMSE of Forces 
[kcal/mol/Å2] 
GB 13.09 ± 9.33 1.377 
Tan 1.34 ± 1.79 1.977 
Swanson 8.72 ± 7.40 0.616 
Our PB 0.32 ± 0.31 0.740 
 
(b) Performance on test set molecules 
Implicit Solvents 
AAE and RMSE of 
Solvation Free Energy  
[kcal/mol] 
RMSE of Forces 
[kcal/mol/Å2] 
GB 23.27 ± 27.63 1.384 
Tan 21.24 ± 9.32 1.715 
Swanson 29.85 ± 13.04 0.767 
Our PB 2.43 ± 2.39 0.958 
 
 
 
 
  
- 83 - 
 
Table 2-5 Binding Free Energy Calculated by One Trajectory Method of MM-PBSA 
Experimental and calculated binding free energies of each peptide are listed. Relative 
binding free energy compared to TSFAEYWNLLSP is also listed in brackets. All 
experimental data were derived from ref. [46]. 
 
 
Experimental 
Relative Binding 
Free Energy 
[kcal/mol] 
Calculated Binding Free Energy [kcal/mol] 
GB Tan Swanson Our PB 
ASFAEYWNLLSP 0.39 
-46.41 
(-3.19) 
-56.63 
(-3.87) 
-72.96 
(-2.16) 
-67,39 
(-1.21) 
TAFAEYWNLLSP 1.24 
-46.78 
(-3.55) 
-56.92 
(-4.16) 
-72.69 
(-1.90) 
-67.52 
(-1.34) 
TSAAEYWNLLSP 5.46 
-35.39 
(+7.83) 
-43.26 
(+9.49) 
-57.03 
(+13.76) 
-53.66 
(+12.52) 
TSFAEYWNLLSP 0 
-43.23 
(0) 
-52.75 
(0) 
-70.79 
(0) 
-66.18 
(0) 
TSFAAYWNLLSP 1.10 
 -41.13 
 (+2.10) 
-49.29 
(+3.47) 
-66.56 
(+4.23) 
-62.40 
(+3.78) 
TSFAEAWNLLSP 3.06 
-41.01 
 (+2.22) 
-48.77 
(+3.99) 
-65.38 
(+5.41) 
-61.08 
(+5.10) 
TSFAEYANLLSP 6.31 
-34.41 
 (+8.82) 
-39.22 
(+13.54) 
-57.37 
(+13.42) 
-54.29 
(+11.89) 
TSFAEYWALLSP -1.10 
-44.57 
 (-1.34) 
-53.13 
(-0.37) 
-69.46 
(+1.33) 
-65.41 
(+0.77) 
TSFAEYWNALSP -0.17 
-44.05 
(-0.82) 
-56.05 
(-3.30) 
-69.59 
(+1.20) 
-65.42 
(+0.76) 
TSFAEYWNLASP 3.28 
-40.83 
(+2.40) 
-50.25 
(+2.50) 
-65.10 
(+5.69) 
-60.87 
(+5.31) 
TSFAEYWNLLAP 0.12 
-42.67 
(+0.55) 
-51.05 
(+1.71) 
-66.44 
(+4.35) 
-62.06 
(+4.11) 
TSFAEYWNLLSA -0.25 
-41.41 
(+1.82) 
-52.44 
(+0.31) 
-67.79 
(+3.00) 
-63.83 
(+2.34) 
Correlation 
Coefficient  0.838 0.850 0.858 0.881 
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Table 2-6 Binding Free Energy Calculated by Two Trajectory Method of MM-PBSA 
Experimental and calculated binding free energies of each peptide are listed. Relative 
binding free energy compared to TSFAEYWNLLSP is also listed in brackets. All 
experimental data were derived from ref. [46]. 
 
 
Experimental 
Relative Binding 
Free Energy 
[kcal/mol] 
Calculated Binding Free Energy [kcal/mol] 
GB Tan Swanson Our PB 
ASFAEYWNLLSP 0.39 
-47.07 
(-6.49) 
-59.03 
(-9.78) 
-72.75 
(-6.59) 
-66.80 
(-4.18) 
TAFAEYWNLLSP 1.24 
-46.20 
(-5.62) 
-57.97 
(-8.71) 
-73.33 
(-7.17) 
-67.45 
(-4.84) 
TSAAEYWNLLSP 5.46 
-38.40 
(2.19) 
-49.86 
(-0.60) 
-61.92 
(4.24) 
-58.07 
(4.55) 
TSFAEYWNLLSP 0 
-40.59 
(0.00) 
-49.26 
(0.00) 
-66.16 
(0.00) 
-62.62 
(0.00) 
TSFAAYWNLLSP 1.10 
-41.45 
(-0.87) 
-50.54 
(-1.28) 
-66.99 
(-0.84) 
-62.81 
(-0.19) 
TSFAEAWNLLSP 3.06 
-41.81 
(1.22) 
-50.44 
(-1.18) 
-66.98 
(-0.83) 
-62.85 
(-0.23) 
TSFAEYANLLSP 6.31 
-37.12 
(3.47) 
-42.75 
(6.51) 
-59.93 
(6.23) 
-55.20 
(7.42) 
TSFAEYWALLSP -1.10 
-43.73 
(-3.14) 
-52.22 
(-2.96) 
-67.64 
(-1.49) 
-63.66 
(-1.05) 
TSFAEYWNALSP -0.17 
-43.73 
(-3.15) 
-57.97 
(-8.71) 
-68.98 
(-2.83) 
-66.46 
(-3.84) 
TSFAEYWNLASP 3.28 
-45.31 
(-4.72) 
-55.01 
(-5.75) 
-64.19 
(1.97) 
-60.79 
(1.82) 
TSFAEYWNLLAP 0.12 
-40.64 
(-0.05) 
-48.90 
(0.36) 
-63.25 
(2.90) 
-59.72 
(2.90) 
TSFAEYWNLLSA -0.25 
-39.74 
(0.85) 
-52.73 
(-3.47) 
-66.41 
(-0.26) 
-62.46 
(0.16) 
Correlation 
Coefficient  0.470 0.509 0.615 0.708 
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Chapter 3 
in silico 
Peptide Screening  
against SH2 domains 
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3.1. Introduction 
In chapter 1, we improved the prediction accuracy of binding conformations of 
peptides to their target proteins by developing our original program for molecular docking. 
In chapter 2, we parameterized new PB radii and showed high performances on 
estimations of polar contributions of the solvation free energies of single molecules and 
on predictions of binding affinities by Molecular Mechanics and Poisson-Boltzmann 
Surface Area (MM-PBSA) method [51]. In this chapter, we combined our improved 
methods and applied them to in silico screening of peptides against various Src Homology 
2 (SH2) domains. 
SH2 domain is one of modules of adaptor proteins. Adaptor proteins basically have 
no catalytic activities, but they have several protein-binding modules. Each module of 
adaptor proteins physically associates with upstream or downstream signaling proteins in 
a signaling pathway and enhances the formation of protein complexes. SH2 domains 
recognize phosphorylated states of the specific tyrosine of upstream proteins and bind 
only to the phosphorylated state of the tyrosine (pY). On the other hand, SH3 domains 
binds proline-rich amino acid sequences of downstream signaling proteins. Adaptor 
proteins recruit upstream and downstream signaling proteins via binding of specific 
regions of signaling proteins to each protein-binding module of adaptor proteins. 
Adaptor proteins are involved in some cancer cell activities, therefore, they are 
attractive therapeutic targets [66, 67]. For example, an activity level of Src proteins 
increased in many types of tumors. An activity level of Crk proteins is also elevated in 
many types of tumors, especially in the colon and lung cancers [68]. Grb2 proteins are 
involved in inappropriate cell proliferations in some leukemia [69] and in breast and 
ovarian cancers [70]. Then, preventing the signals mediated by adaptor proteins are 
promising approaches for several cancer therapies. Many researchers studied the design 
of peptide or small molecule inhibitors binding to SH2 or SH3 domains [71-73]. 
SH2 domains are optimal systems to examine the ability to discriminate binding 
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peptides for in silico screening method. SH2 domains are highly structurally conserved 
modules, but they selectively bind to signaling proteins. Each SH2 domain has a certain 
preferential binding sequence, called binding motif [74]. For example, pYxxI, pYxxP and 
pYxNx is the binding motif for Src, Crk and Grb2 SH2 domains, respectively (x indicates 
any amino acids). Recently, Liu et al. investigated the binding selectivities of 50 SH2 
domains by SPOT analysis [75]. In this chapter, we utilized this experimental data to 
measure the performances of our screening method. 
In this chapter, we tried to discriminate binding peptides of several SH2 domains 
from a small peptide library using our screening method. Our goal in this chapter is to 
find the optimal condition of peptide screening for each protein toward the large scale of 
screening. Our screening method was based on the molecular docking and MM-PBSA 
rescoring. Structures of ligand-receptor complexes were predicted by our molecular 
docking program, and binding affinities were estimated by MM-PBSA method using our 
PB radii. We compared our method with conventional methods in terms of the 
performances on peptide screening. Furthermore, we examined the dependency of the 
conformations of the receptor proteins on the screening performance. 
In addition, we investigated the effects of the reorganization of ligand molecules on 
peptide screening. In other words, we applied the two trajectory method to the docking-
based screening. The reorganization effects are explained as a free energy difference 
caused by a conformational change through the binding process. Both the ligand and the 
receptor molecules usually change their conformations into suitable conformations 
according to their binding partners. The free energy difference associating these 
conformational changes are unfavorable for each molecule (it is also referred as a restraint 
energy), however free energies obtained from the binding partner overcomes these free 
energy loss and lead to the formation of the complex structure. In the one trajectory 
method, the unstable binding conformations of the ligand molecule in the complex 
structure are permitted because the restraint energies are completely neglected. Only (so-
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called) interaction energies are the interests in the one trajectory methods. However, it is 
questionable whether these binding conformations can represent the correct binding 
conformations. 
The reorganization effects are more effective for molecules having the high 
conformational flexibility, like peptides. In chapter 2, we applied the two trajectory 
method of MM-PBSA to 12 MDM2-peptide complexes. Because binding peptides used 
in chapter 2 were in the forms of α-helixes, the reorganization effects were potentially 
small. Peptides used in this chapter, which are adjusted to 8-mer length, has no stable 
secondary structures of proteins. Thus, the reorganization effects of peptides may 
influence strongly the performances on peptide screening. 
In this chapter, we performed additional conformational search of peptides in the 
unbound state. We used the same program described in chapter 1 to search stable 
conformations of peptides. Because the conformations of unbound peptides are highly 
fluctuated in solvents, just one stable conformation predicted by our program does not 
reflect the actual conformations of peptides in waters. However, the energy difference 
between the bound- and the unbound state of peptides may be useful as a rough estimation 
of the restraint energy. 
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3.2. Methods 
3.2.1. Experimental Data 
Our study was based on experimental data by Liu [75]. Liu examined the interactions 
between 192 phosphorylated peptides and 50 SH2 domains by SPOT analysis. We 
selected four SH2 domains, Crk, Grb2, Nck1, and Src SH2 domains, as target proteins of 
our peptide screening from 50 SH2 domains, because their 3D structures of peptide-SH2 
complexes were available. We used 100 peptides illustrated in Figure 2 of Liu’s paper as 
a small set of the peptide library. Peptides having more than 3 times greater binding 
intensity than the average intensity of 100 peptides were regarded as binding peptides: 16 
peptides for Crk, 11 peptides for Grb2, 14 peptides for Nck1, and 14 peptides for Src SH2 
domains were selected as the binding peptides respectively. 
 
3.2.2. Procedures of Screening 
Our protocol to predict the binding affinity of each peptide is as follows: we first 
prepared linearly extended structures of the peptide. We carried out the molecular docking 
using the extended structure as the input structure and obtained 30 candidate binding 
conformations of the peptide-receptor complexes. We also carried out the conformational 
search of the peptide in the unbound state and obtained 30 candidate-conformations. All 
predicted structures were energetically minimized in the box of TIP3P waters. After 
minimizations, all solvents and ions were removed. Receptor conformations were fixed 
in the whole processes. 
We calculated the binding affinities by MM-PBSA method as the rescoring of the 
docked structures. First, we calculated the free energy of 30 complex structures and 30 
ligand structures of each peptide by MM-PBSA method. Next, we selected the most stable 
structures of the complex and of the peptide structure in terms of the calculated free 
energies. We calculated binding affinities in two manners: the one trajectory method and 
the two trajectory method. In the one trajectory method, conformations of the receptor 
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and ligand molecule were extracted from the complex structure. The binding affinity ΔG 
was calculated as follows: 
𝛥𝐺 = 𝐺𝑐𝑜𝑚 − (𝐺𝑟𝑒𝑐,𝑏𝑜𝑢𝑛𝑑 + 𝐺𝑙𝑖𝑔,𝑏𝑜𝑢𝑛𝑑) 
where Gcom is the free energy calculated by MM-PBSA using the complex structure 
predicted by molecular docking, Grec,bound and Glig,bound is the free energy calculated by 
MM-PBSA using the receptor and ligand structure extracted from the complex structure. 
On the other hand, two trajectory methods uses two predicted structures of the complex 
and the peptide. The binding affinity ΔG was calculated as folllows: 
𝛥𝐺 = 𝐺𝑐𝑜𝑚 − (𝐺𝑟𝑒𝑐,𝑏𝑜𝑢𝑛𝑑 + 𝐺𝑙𝑖𝑔,𝑢𝑛𝑏𝑜𝑢𝑛𝑑) 
where Glig,unbound is the free energy calculated by MM-PBSA with the ligand structure 
predicted by conformational search in the unbound state. 
 
3.2.3. Structural Preparation 
In chapter 1, we demonstrated the efficacy of Molecular Dynamics (MD) 
simulations on structural preparations for our molecular docking. In this chapter, we 
prepared five conformations of each peptide-receptor complexes by MD simulations. The 
initial structures were downloaded from the PDB web site. PDB IDs are 1JU5 [26] for 
Crk, 1JYR [27] for Grb2, 2CI9 [76] for Nck1, and 1KC2 [28] for Src SH2 domains. The 
length of amino acids of all ligand peptides were adjusted to 8-mer (X-2-X-1-pY0 -X+1-
X+2-X+3-X+4-X+5: each residue was named after the relative positions from pY for 
convenience). All protonation states of the solute were determined by the protonate3D 
module of MOE [43]. All solutes were soaked in the box of TIP3P waters. A total of 13 
ns MD simulations was performed on each complex molecules. We used the receptor 
conformations at 5, 7, 9, 11, and 13 ns of MD simulations (named MD5, MD7, MD9, 
MD11, and MD13 for convenience). The position of ligand peptides of each 
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conformations were also used as reference positions of positional restraints. MD 
simulations were carried out using the pmemd module of AMBER 12 [24]. 
 
3.2.4. Molecular Docking 
We carried out the molecular docking using two software: our program accelerated 
by GPU described in chapter 1 and GOLD [77]. In our program, the number of parent-
conformations was set to 1,000 and the number of child-conformations per parent-
conformation was 30. Positional restraints were applied as follows: the position of the 
phosphorus atom in the phosphorylated tyrosine were fixed during simulations. Cα atoms 
at -1, 0, +1, +2, +3, and +4 residues were harmonically restrained with the force constant 
of 10.0 kcal/mol/Å2 when the atoms are located more than 3.0 Å away from the reference 
positions. We carried out the molecular docking three times, and each 10 conformations 
from top 10 clusters were used for following processes. 
The force field for the phosphorylated tyrosine (pY) was derived from the work of 
Homeyer et al [78]. 
For GOLD, positional restraints were applied to the phosphorus atom of the 
phosphorylated tyrosine and every Cα atom. Constraint weights were 30 and the 
constraint radius is 3.0 Å from reference positions. The binding sites were determined 
with the center point of the reference ligand structure with sphere radius 20Å. A searching 
efficiency was set to 200%. The number of docking runs was 30, and the top conformation 
of each docking run were used for following processes. All other parameters remain as 
defaults. 
 
3.2.5. Rescoring by MM-PBSA 
We calculated the binding affinities using various MM-PBSA methods developed by 
Tan et al. [36], Swanson et al. [35] and us. Simulation conditions was the same described 
in chapter 2. We designed PB radii for the phosphorylated tyrosine in the same manners 
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described in Chapter 2 and used for our PB method. For Swanson’s PB, the BONDI radii 
with optimal offset for smoothing dielectric functions were used [35, 79]. 
3.2.6. Performance Metric 
We used the area under the receiver operating characteristics curve (ROC AUC) to 
measure the performances of peptide screening. ROC AUC was often used as a metric of 
the performance to discriminate binders from non-binders in virtual screening [80]. ROC 
AUC ranges from 0 to 1. ROC AUC of 0.5 corresponds to the random selection. Higher 
ROC AUC indicated a better performance of the screening method. We used ROC AUC 
of 0.7 as a criterion for good performances. 
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3.3. Results 
3.3.1. Screening Performance of GOLD 
Before discussing our method, we discuss the performance of conventional docking 
program, GOLD, on peptide screening. We described in previous chapter that GOLD is 
incapable of predicting correct binding poses without any positional restraints. Here, we 
discuss the performance of GOLD with the positional restraints: Table 3-1 lists the ROC 
AUCs of each screening using only GOLD: the conformations of the peptide-receptor 
complexes were predicted by GOLD, and docking scores were used as binding affinities. 
ROC AUCs higher than 0.7 were observed in only 1 of 4 proteins. This result indicated 
that GOLD was incapable of predicting correct binding affinities of peptides. 
 
3.3.2. GOLD with MM-PBSA Rescoring 
We measured performances of combined methods of GOLD and MM-PBSA 
rescoring where the binding conformations of the peptide-receptor complexes were 
predicted by GOLD and binding affinities were predicted various MM-PBSA rescoring.  
In all proteins, the best ROC AUC values were higher than those using only GOLD. 
The deviations of ROC AUCs are also increased in all proteins. It suggested the MM-
PBSA rescoring is sensitive to the binding conformations. 
MM-PBSA method using Swanson’s PB showed the highest performance in 2 of 3 
proteins. MM-PBSA method using our PB method showed the highest performance in 1 
of 3 proteins. The ROC AUCs of these two methods are similar, because these two PB 
methods was the same except for the PB radii set. It resulted in the high correlation 
coefficients, 0.873, between the binding affinities of peptides on the Crk MD9 structure 
calculated by our and Swanson’s method. On the other hand, the correlation coefficient 
of Tan’s PB with Swanson’s and our PB is 0.654 and 0.709, respectively. This indicated 
the PB methods strongly influence the screening performances.  
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3.3.3. Our Molecular Docking with MM-PBSA Rescoring 
We measured performances of screening methods using our program for molecular 
docking and various MM-PBSA rescoring (Table 3-3). For all proteins, the best ROC 
AUC values are higher than those using combined methods of GOLD and MM-PBSA 
rescoring. This result indicated the superiority of our molecular docking. 
In most structures of Crk, Nck1, and Src, the ligand reorganization affected 
positively to the screening performance. The impact of the reorganization effects seems 
to be relatively small for MM-PBSA rescoring using Tan’s PB method. The screening 
performances of Grb2 were decreased by including the reorganization effects except for 
Swanson’s PB. By including the reorganization effects, MM-PBSA rescoring based on 
Swanson’s and our PB methods accomplished the ROC AUC almost higher than 0.7 in 
all proteins.  
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3.4. Discussions 
3.4.1. Ligand Reorganization Effects 
Including reorganization effects of ligand molecules improved the screening 
performances on Crk, Nck, and Src SH2 domains. This effect decreased the ROC AUCs 
in some cases, but this losses were quite small in most cases. The reorganization effects 
were less effective for peptide screening of Grb2 SH2 domain. One plausible explanation 
for this results is the conformational flexibility of the ligand molecule in the bound state. 
The N-terminal and C-terminal regions of Grb2-binding peptides are exposed to solvents. 
We observed highly fluctuations of these regions (Figure 3.1). If ligand peptides change 
their conformations freely even in the bound state, it is unreasonable to represent binding 
conformations of peptides using just a single stable conformation predicted by molecular 
docking. Furthermore, considering this situation, the reorganization effects cannot be 
represented because the two trajectory method estimate the energy loss between only two 
stable conformations in bound and unbound states. Multiple conformations may be 
required for both the bound and the unbound state of ligand molecules to describe the 
conformational change in the fluctuated structures. One trajectory method seems to be 
rather appropriate for the highly fluctuated peptides, because it ignore the conformational 
change of peptides completely. The reorganization effects should be applied after the 
careful considerations of the conformational flexibility of peptide in the bound state. 
The reorganization effects seems to work favorably to molecules having relatively 
less conformational flexibility, such as peptides including a proline residue. Because the 
conformational change between in the bound and the unbound state are less small for 
these molecules, the expected restraint energies tended to be small. There is a potential 
bias to increase the binding affinities for specific kinds of molecules. In our study, the 
binding motif of Crk SH2 domain, pYxxP, is relevant to this problem. We examined the 
high performances for Crk SH2 domain was caused by such biases or not. We measured 
the discrimination performances of known non-binding peptide sequences having pYxxP 
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motif. In our peptide library, 8 from100 peptides have pYxxP sequence but do not bind 
to Crk SH2 domain. ROC AUC for discriminating non-binding pYxxP peptides are listed 
in Table 3-4. This result indicated that our screening can discriminate pYxxP binding 
peptides from pYxxP non-binding peptides. The reorganization effects worked 
unfavorably to pYxxP non-binding peptides. MM-PBSA using Swanson’s PB method 
showed subtly high ROC AUCs compared to other implicit solvents, which may be more 
problematic at the large scale of the peptide screening. 
 
3.4.2. Negative Effects of the Use of MD Structure on Src SH2 
The screening performances on Src SH2 domains were relatively low compared to 
other proteins. It was caused by structures used in the screening and the selection of the 
peptide library. 
We described the importance of MD simulations to generate structures used in 
molecular docking in chapter 1. MD simulations can equilibrate molecular systems and 
generate stable conformations of molecules. As a result, these conformation of the 
receptor proteins were optimized according to their ligand molecules. It is known as an 
induced fit. Because we used the induced fitted conformations of the receptor proteins for 
peptide screening, there are some biases on discrimination of binding peptides. We did 
not get rid of these biases because the conformation of the receptor proteins were fully 
fixed in the whole process. In the case of peptide screening for Src SH2 domain, the amino 
acid sequences of the ligand peptide is PQpYEEIPI. The conformations of Src SH2 
domain were optimized to its sequence. The binding motif of Src SH2 domain is known 
as pYxx(I/M/L); however, only 4 of 14 binding sequences from our peptide library fulfill 
this binding motif. Especially, the binding sequences satisfying pYxxI was just one 
sequence: EDpYGDIEI. This should be a major reasons for relative low ROC AUCs for 
Src SH2 domain. Perhaps, experimental data for Src SH2 domains did not meet the 
requirement to measure the performances of peptide screening. We will confirm to 
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screening performances of Src SH2 by rebuilding the peptide library for screening. 
 
3.4.3. Best Implicit Solvents for MM-PBSA 
MM-PBSA using Swanson’s PB method showed totally high performances on four 
proteins. However, there should be any biases considering the results in chapter 2. We 
described the underestimations of the solvation free energies for negatively charged 
molecules for Swanson’s PB method in chapter 2. In general, the binding peptides to SH2 
domains are negatively charged. Therefore, the use of Swanson’s method is inadvisable. 
Furthermore, the reorganization effects are useful for peptides as long as the peptides are 
less free in the bound state. However, the errors of the solvation free energy were 
increased for Swanson’s PB by including the reorganization effects. We consider the only 
our PB method can estimate the solvation free energy of the solute correctly. 
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3.5. Conclusions 
We measured our screening performances on four SH2 domains compared to 
conventional methods. We demonstrated the inability of conventional docking score to 
discriminate the binding peptides from the other. MM-PBSA rescoring with predicted 
structures by GOLD improved on the screening performances, however, our molecular 
docking showed further improvements in ROC AUCs. 
It needs careful considerations for including the ligand reorganization effect in 
peptide screening. It may be useless if ligand peptides have high conformational 
flexibility even in bound states. These characteristics can be investigated in advance using 
MD simulations of the peptide-protein complex structure. MD simulations are also useful 
for generation the structure used in screenings. Because MM-based binding affinity 
predictions are highly dependent on the receptor conformations, the pre-screening using 
a small library against several conformations is essential. 
MM-PBSA rescoring using Swanson’s PB method showed high performances on 
peptide screening. However, the use of their PB radii set is not good idea because SH2-
binding peptides are generally charged because of the inaccuracy of Swanson’s PB for 
charged residues. The errors of the solvation free energies affect unfavorably to the large 
scale of peptide screening. 
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3.6. Figures 
 
 
Figure 3.1 Superimposed Structures of Grb2-peptide complexes 
Snapshots extracted every 1 nsec from 13 nsec MD simulations of Grb2-peptide 
complexes are superimposed. Backbones are represented by the ribbons. The 
phosphorylated tyrosine and the asparagine in the binding motif of Grb2 SH2 domain are 
represented as sticks. Receptor molecules are illustrated in green and ligand molecules 
are illustrated in cyan. 
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3.7. Tables 
 
Table 3-1 Screening Performance of GOLD 
The values of ROC AUC are listed. Best ROC AUC for each protein is highlighted in 
bold. 
 Crk Grb2 Nck1 Src 
MD5 0.746 0.763 0.458 0.432 
MD7 0.520 0.557 0.654 0.469 
MD9 0.545 0.715 0.470 0.535 
MD11 0.516 0.779 0.586 0.561 
MD13 0.496 0.404 0.643 0.420 
Average 0.565 0.644 0.562 0.483 
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Table 3-2 Screening Performance with GOLD and MM-PBSA 
The values of ROC AUC are listed. Best ROC AUC for each protocol is highlighted in 
bold. 
(a) Crk SH2 domain 
 Tan Swanson Our PB 
MD5 0.623 0.663 0.637 
MD7 0.569 0.354 0.407 
MD9 0.575 0.524 0.521 
MD11 0.664 0.530 0.523 
MD13 0.593 0.503 0.501 
Average 0.605 0.515 0.518 
 
(b) Grb2 SH2 domain 
 Tan Swanson Our PB 
MD5 0.733 0.740 0.655 
MD7 0.810 0.787 0.830 
MD9 0.669 0.740 0.647 
MD11 0.886 0.730 0.813 
MD13 0.633 0.662 0.709 
Average 0.746 0.732 0.731 
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(c) Nck1 SH2 domain 
 Tan Swanson Our PB 
MD5 0.363 0.660 0.601 
MD7 0.508 0.724 0.647 
MD9 0.446 0.609 0.605 
MD11 0.545 0.576 0.581 
MD13 0.438 0.673 0.624 
Average 0.460 0.648 0.612 
 
 
(d) Src SH2 domain 
 Tan Swanson Our PB 
MD5 0.525 0.608 0.587 
MD7 0.584 0.535 0.536 
MD9 0.428 0.590 0.581 
MD11 0.513 0.599 0.622 
MD13 0.547 0.583 0.556 
Average 0.519 0.583 0.576 
 
  
- 103 - 
 
Table 3-3 Screening Performance with Our Program and MM-PBSA Rescoring 
The values of ROC AUC are listed. Left values in each PB method are ROC AUCs of 
screening not including the reorganization effects of peptides. Right values are those of 
screening including the reorganization effects of peptides. Best ROC AUC for each 
protocol is highlighted in bold. 
(a) Crk SH2 domain 
 Tan Swanson Our PB 
MD5 0.693 0.719 0.635 0.705 0.609 0.759 
MD7 0.507 0.651 0.379 0.632 0.502 0.646 
MD9 0.580 0.616 0.725 0.806 0.750 0.773 
MD11 0.722 0.706 0.589 0.792 0.554 0.734 
MD13 0.633 0.696 0.583 0.727 0.532 0.804 
MD15 0.644 0.766 0.529 0.742 0.592 0.841 
Average 0.630 0.692 0.573 0.734 0.590 0.760 
 
(b) Grb2 SH2 domain 
 Tan Swanson Our PB 
MD5 0.888 0.866 0.901 0.813 0.890 0.764 
MD7 0.816 0.719 0.698 0.755 0.862 0.734 
MD9 0.811 0.783 0.723 0.772 0.845 0.640 
MD11 0.867 0.832 0.753 0.813 0.854 0.799 
MD13 0.635 0.627 0.673 0.741 0.863 0.660 
MD15 0.668 0.558 0.717 0.653 0.717 0.609 
Average 0.781 0.731 0.744 0.758 0.839 0.701 
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(c) Nck1 SH2 domain 
 Tan Swanson Our PB 
MD5 0.414 0.473 0.665 0.733 0.653 0.613 
MD7 0.568 0.621 0.679 0.728 0.528 0.661 
MD9 0.571 0.586 0.699 0.706 0.638 0.625 
MD11 0.470 0.605 0.747 0.790 0.689 0.725 
MD13 0.686 0.660 0.666 0.717 0.648 0.642 
MD15 0.716 0.822 0.797 0.819 0.792 0.824 
Average 0.571 0.628 0.709 0.749 0.658 0.681 
 
(d) Src SH2 domain 
 Tan Swanson Our PB 
MD5 0.453 0.538 0.620 0.680 0.576 0.609 
MD7 0.605 0.606 0.603 0.699 0.547 0.585 
MD9 0.524 0.537 0.540 0.633 0.610 0.602 
MD11 0.578 0.564 0.567 0.703 0.591 0.693 
MD13 0.453 0.496 0.488 0.601 0.488 0.497 
MD15 0.474 0.535 0.496 0.631 0.442 0.639 
Average 0.515 0.546 0.552 0.657 0.542 0.604 
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Table 3-4 Screening Performance for nonbinding pYxxP sequences 
The values of ROC AUC are listed. Left values in each PB method are ROC AUCs of 
screening not including the reorganization effects of peptides. Right values are those of 
screening including the reorganization effects of peptides. Best ROC AUC for each 
protocol is highlighted in bold. 
 
Crk SH2 domain 
 Tan Swanson Our PB 
MD5 0.558 0.450 0.572 0.635 0.760 0.557 
MD7 0.504 0.484 0.482 0.473 0.486 0.467 
MD9 0.552 0.486 0.620 0.537 0.573 0.500 
MD11 0.554 0.527 0.490 0.500 0.427 0.493 
MD13 0.440 0.440 0.628 0.654 0.709 0.592 
MD15 0.484 0.598 0.550 0.561 0.476 0.554 
Average 0.515 0.498 0.557 0.560 0.572 0.527 
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Conclusion 
Molecular docking-based approaches on in silico screening have been developed for 
the design of drug like small molecules. Because peptides have different characteristics 
from drug like small molecules, these approaches cannot be applied for peptide design.  
Molecular docking have two main purposes: prediction of binding conformations 
and binding affinities. These two purposes are accomplished using the scoring functions. 
We developed our docking program for peptide design. We incorporated molecular 
mechanics (MM) into scoring functions, because MM have been well studied using 
proteins and peptides. We also incorporated implicit solvent model (generalized born 
model) into our scoring functions because many polar functional groups of peptides 
require the precise descriptions of interactions with solvents. Our program showed high 
performances on prediction of binding conformations of the peptide to its receptor 
proteins. In addition, our program was accelerated by the GPGPU technology. We could 
process the computing for the molecular docking more than 100 times faster than a single 
core of CPU. 
We also tried to improve an accuracy of the molecular mechanics and Poisson-
Boltzmann surface area (MM-PBSA) method used in rescoring of binding affinities. We 
improved the accuracy of Poisson-Boltzmann (PB) implicit solvents by modifying PB 
radii, which are important parameter for PB calculations. Our PB method showed high 
performances on the estimation the polar contributions of solvation free energy of single 
molecules. We also demonstrated improved accuracies for prediction of binding affinities 
by MM-PBSA method. 
Combining our improved methods showed high performances on peptide screening 
of several SH2 domains. We incorporated the reorganization effects of ligand molecules 
into docking-based approaches. The reorganization effects are effective for Crk, Nck1, 
and Src SH2 domains but less effective for Grb2 SH2 domain. These efficiencies may 
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relevant with the conformational flexibility of the ligand molecules in the bound state. 
We must take careful considerations whether the reorganization effects are included or 
not to docking-based approches. Molecular dynamics simulations are useful to determine 
the screening protocols such as positional restraints and the reorganization effects. 
We showed the beneficial information for docking-based peptide screening through 
this study. Our two improved methods are first important steps for accurate prediction of 
binding affinities of peptides.  
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